<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Pituitary via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pituitary' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Pituitary&t=Pituitary&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 15:09:02 +0100</lastBuildDate>
        <item>
            <title>Tumors invading the cavernous sinus that cause internal carotid artery compression are rarely pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5667689&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj037633867j25478%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is a clinical impression that when tumors invade the cavernous sinus, compression of the internal carotid artery is
 rare with pituitary adenomas and more common with other types of lesions but there are no actual data to support this impression.
 To confirm the impression that the finding of internal carotid artery compression by tumors invading the cavernous sinus is
 inconsistent with a diagnosis of a pituitary adenoma, we performed a retrospective analysis of MRI scans performed between
 2000 and July 2009. An initial search of the radiology database was performed using the terms “invasive mass cavernous MRI”
 and subsequent refinement narrowed the evaluation to 141 patients with cavernous sinus invasion by sellar/parasellar tumors
 for whom there were cli...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667689</comments>
            <pubDate>Fri, 03 Feb 2012 17:52:53 +0100</pubDate>
            <guid isPermaLink="false">5667689</guid>        </item>
        <item>
            <title>Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas</title>
            <link>http://www.medworm.com/index.php?rid=5667690&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fem40703751x14j47%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We evaluated the efficacy of Gamma knife stereotactic radiosurgery (GKSR) as an adjunctive management modality for patients
 with drug resistant or intolerant cavernous sinus invasive prolactinomas. Twenty-two patients with cavernous sinus invasive
 prolactinoma underwent GKSR between 1994 and 2009. Thirteen patients were dopamine agonist (DA) resistant. Six patients were
 intolerant to DA. Three patients chose GKSR as their initial treatment modality in hopes they might avoid life long suppression
 medication. The median tumor volume was 3.0&amp;nbsp;cm3 (range 0.3–11.6). The marginal tumor dose (median&amp;nbsp;=&amp;nbsp;15&amp;nbsp;Gy, range 12–25&amp;nbsp;Gy) prescribed was based on the dose delivered to
 the optic apparatus. The median follow-up interval was 36&amp;nbsp;months (range...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667690</comments>
            <pubDate>Thu, 02 Feb 2012 18:15:59 +0100</pubDate>
            <guid isPermaLink="false">5667690</guid>        </item>
        <item>
            <title>A review of guidelines for use of growth hormone in pediatric and transition patients</title>
            <link>http://www.medworm.com/index.php?rid=5638931&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe5m2074p54011v16%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Growth hormone (GH) is approved by the US Food and Drug Administration (FDA) for use in pediatric patients with disorders
 of growth failure or short stature and in adults with growth hormone deficiency (GHD) and HIV/AIDS wasting and cachexia. For
 pediatric patients, guidelines for the use of GH have been developed by several organizations that have identified specific
 criteria for initiating GH therapy for each FDA-approved indication. Guidelines for adults have also been developed and include
 recommendations for transition (adolescent) patients with GHD. These patients are often treated with GH as children but may
 require continued treatment as young adults to attain full skeletal mineralization and improve cardiovascular risk factors.
 Adult and pediatric guideli...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638931</comments>
            <pubDate>Tue, 24 Jan 2012 07:30:11 +0100</pubDate>
            <guid isPermaLink="false">5638931</guid>        </item>
        <item>
            <title>Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity?</title>
            <link>http://www.medworm.com/index.php?rid=5582815&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F781846537781124g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Previous case reports and retrospective studies suggest that pituitary dysfunction may occur after acute bacterial or viral
 meningitis. In this prospective study we assessed the pituitary functions, lipid profile and anthropometric measures in adults
 with acute bacterial or viral meningitis. Moreover, in order to investigate whether autoimmune mechanisms could play a role
 in the pathogenesis of acute meningitis-induced hypopituitarism we also investigated the anti-pituitary antibodies (APA) and
 anti-hypothalamus antibodies (AHA) prospectively. Sixteen patients (10 males, 6 females; mean&amp;nbsp;±&amp;nbsp;SD age 40.9&amp;nbsp;±&amp;nbsp;15.9) with acute
 infectious meningitis were included and the patients were evaluated in the acute phase, and at 6 and 12&amp;nbsp;months after the ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582815</comments>
            <pubDate>Sat, 07 Jan 2012 16:55:14 +0100</pubDate>
            <guid isPermaLink="false">5582815</guid>        </item>
        <item>
            <title>Measurement of oxidative stress and endothelial dysfunction in patients with hypopituitarism and severe deficiency adult growth hormone deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5572575&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn88n636810611380%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients with adult GH deficiency (AGHD) have a high cardiovascular risk and probably an alteration of the oxidative balance,
 although evidence is lacking. To evaluate the presence of endothelial dysfunction and oxidative stress in patients with AGHD.
 Biochemical parameters of oxidative stress and endothelial dysfunction were compared in 25 patients with previously untreated
 AGHD and 25 healthy controls matched by age and sex. Multivariate analysis was performed to identify independent predictors
 of oxidative stress. Vascular function of subcutaneous resistance arteries was also analyzed by means of wire myography in
 7 patients with untreated AGHD and in 7 healthy controls with similar characteristics. The values of C-reactive protein, interleukin-6
 (IL-6) and tum...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572575</comments>
            <pubDate>Fri, 06 Jan 2012 16:48:01 +0100</pubDate>
            <guid isPermaLink="false">5572575</guid>        </item>
        <item>
            <title>First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment</title>
            <link>http://www.medworm.com/index.php?rid=5572576&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk05515q6335h427k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In prolactin-secreting giant adenomas, cabergoline treatment is the first line approach. Surgery and/or radiotherapy are indicated
 when the tumour is resistant to medical treatment and continues growing, causing visual field impairment. Data concerning
 other therapeutic approach are scanty. Although PRL-secreting tumours may express somatostatin receptors type 2, 3 and 5,
 somatostatin analogs treatment is generally ineffective and peptide receptor radionuclide therapy (PRRT) has never been reported.
 A 58&amp;nbsp;year-old woman complaining of severe neurological symptoms caused by a giant prolactinoma, relapsing after surgery and
 not-responding to dopamine-agonists and octreotide LAR treatment, underwent four cycles of PRRT with 111-Indium-DTPA-octreotide
 with remarka...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572576</comments>
            <pubDate>Fri, 06 Jan 2012 06:45:06 +0100</pubDate>
            <guid isPermaLink="false">5572576</guid>        </item>
        <item>
            <title>Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case–control study</title>
            <link>http://www.medworm.com/index.php?rid=5560742&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7882064642242185%2F</link>
            <description>This study indicates that SSTR5 and SSTR3 are the most frequently expressed
 SSTR subtypes in NFPAs and supports a potential role of SSTR subtypes in stabilization of tumor remnant from NFPAs.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s11102-011-0370-8Authors
		Alessandra Fusco, Division of Endocrinology, School of Medicine, Catholic University, Largo A. Gemelli 8, 00168 Rome, ItalyAntonella Giampietro, Division of Endocrinology, School of Medicine, Catholic University, Largo A. Gemelli 8, 00168 Rome, ItalyAntonio Bianchi, Division of Endocrinology, School of Medicine, Catholic University, Largo A. Gemelli 8, 00168 Rome, ItalyVincenzo Cimino, Division of Endocrinology, School of Medicine, Catholic University, Largo A. Gemelli 8, 00168 Rome, ItalyFrancesca Lugli, Division of End...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5560742</comments>
            <pubDate>Fri, 30 Dec 2011 07:08:17 +0100</pubDate>
            <guid isPermaLink="false">5560742</guid>        </item>
        <item>
            <title>Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?</title>
            <link>http://www.medworm.com/index.php?rid=5525510&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq8885u1n17132530%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;New criteria that define acromegaly remission are more stringent: normal (age/sex-adjusted) insulin-like growth factor type
 1 (IGF-1), growth hormone (GH) random (GHr) &amp;lt;1&amp;nbsp;μg/L, and a GH nadir (GHn) during oral glucose tolerance test (OGTT) of &amp;lt;0.4&amp;nbsp;μg/L.
 Discordance between GH and IGF-1 values is often attributed to somatostatin receptor ligands (SRLs) or radiation. The purpose
 of this study was to evaluate rates of discordant IGF-1 and GH levels in patients with GH secreting adenomas (after pituitary
 surgery), who were naïve to any other treatment. We retrospectively analyzed data over a 5&amp;nbsp;year time period (2006–2010), in
 post-surgery acromegaly patients who had elevated IGF-1 but normal GH levels (per the new cure criteria). Symptoms of a...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5525510</comments>
            <pubDate>Mon, 19 Dec 2011 16:51:07 +0100</pubDate>
            <guid isPermaLink="false">5525510</guid>        </item>
        <item>
            <title>Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=5487647&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy17223k8481p64r0%2F</link>
            <description>In this report we analyzed the complications in 624 procedures of endonasal transsphenoidal endoscopic surgery in the treatment
 of 570 patients with pituitary adenomas. The leading author (MB) operated pituitary adenomas via pure endoscopic endonasal
 transsphenoidal surgery between January 2006 and August 2011 at the Hacettepe University, Department of Neurosurgery in Ankara.
 Complications were assessed in 624 surgical procedures under five groups; rhinological, CSF leaks, infection, vascular and
 endocrinologic complications. We observed a total of 76 complications (12.1%). Rhinological complications occurred in 8 patients
 (1.3%): 4 epistaxis (0.6%) and 4 hyposmia (0.6%). Postoperative CSF leaks occurred in 8 patients (1.3%), and infectious complications
 occurred in 8 patients: 3 cas...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5487647</comments>
            <pubDate>Wed, 07 Dec 2011 10:51:56 +0100</pubDate>
            <guid isPermaLink="false">5487647</guid>        </item>
        <item>
            <title>Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5458409&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7t6w2472t1w34hm1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nonfunctioning pituitary adenomas (NFPA) are typically benign neoplasms that can cause significant morbidity through local
 mass effects. MIB-1/Ki-67 and p53 immuno-reactivity are used to predict aggressive behavior but have known limitations. No
 marker to date is widely used to reliably predict tumor progression. Phospho-histone H3 (pHH3) is a protein phosphorylated
 during chromatin condensation in mitosis, and thus anti-pHH3 immunocytochemistry is able to assess mitotic activity. Study
 objectives were to determine the relationship among pHH3, MIB-1/Ki-67, and p53 in NFPA, and to evaluate the relationship between
 these indices and time to progression (TTP). Seventy-six patients with NFPA operated on by a single neurosurgeon at University
 of Texas M. D. Anderson Ca...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5458409</comments>
            <pubDate>Sat, 26 Nov 2011 16:46:59 +0100</pubDate>
            <guid isPermaLink="false">5458409</guid>        </item>
        <item>
            <title>Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study</title>
            <link>http://www.medworm.com/index.php?rid=5449947&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F212179884624tn61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To evaluate the metabolic effects of first-line somatostatin analogues or surgery in acromegaly. Retrospective, comparative,
 12-month follow-up. Two hundred and thirty one patients (123 men, age 47.32&amp;nbsp;±&amp;nbsp;14.63&amp;nbsp;years) with active acromegaly, first line
 treatments were somatostatin analogues in 151 (65.4%) and surgery in 80 (34.6%). Metabolic syndrome (MS) parameters, glucose,
 insulin and GH during oral glucose tolerance test, stimulated insulin sensitivity by insulin sensitivity index (ISI Matsuda),
 early and total insulin-secretion rate by insulinogenic index and AUCINS, visceral adiposity function, expressed by visceral adipose index (VAI). Somatostatin analogues treatment improved all MS
 parameters and significantly reduced fasting glucose (P&amp;nbsp;...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449947</comments>
            <pubDate>Thu, 24 Nov 2011 17:43:41 +0100</pubDate>
            <guid isPermaLink="false">5449947</guid>        </item>
        <item>
            <title>Ovarian tumor-derived ectopic hyperprolactinemia</title>
            <link>http://www.medworm.com/index.php?rid=5441597&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft743xw7083818312%2F</link>
            <description>We present a case of profound hyperprolactinemia originating from a pituitary adenoma found in the wall of an ovarian dermoid
 and give a broad overview of the condition and literature. Ectopic prolactin production should always be considered in symptomatic
 patients found to have elevated serum levels and no findings on brain imaging.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s11102-011-0366-4Authors
		Autumn F. Elms, Department of Obstetrics and Gynecology, Winnie Palmer Hospital, Orlando Regional Healthcare, 105 West Miller St., Orlando, FL 32806, USAS. J. Carlan, Department of Obstetrics and Gynecology, Winnie Palmer Hospital, Orlando Regional Healthcare, 105 West Miller St., Orlando, FL 32806, USAAmy E. Rich, Department of Pathology, Orlando Regional Healthcare, Orlando, F...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441597</comments>
            <pubDate>Mon, 21 Nov 2011 18:03:34 +0100</pubDate>
            <guid isPermaLink="false">5441597</guid>        </item>
        <item>
            <title>Pituitary immunoexpression of ghrelin in anorexia nervosa</title>
            <link>http://www.medworm.com/index.php?rid=5409154&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw8137k4g83k969l2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ghrelin, an orexigenic hormone, is known to occur in the normal anterior pituitary where its physiologic role is uncertain
 but may include promotion of appetite. We sought to investigate anticipated differences in adenohypophysial and neurohypophysial
 ghrelin immunoexpression between normal subjects and patients with anorexia nervosa who had succumbed to complications of
 the disease. We hypothesized that the glands of anorexia nervosa patients would show relative diminished action in ghrelin
 content. The study included 12 autopsy-derived pituitaries of anorexia nervosa and 10 control glands. The streptavidin-biotin-peroxidase
 complex method and double immunohistochemical staining method were used to determine which cell types expressed both ghrelin
 and adenohypoph...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409154</comments>
            <pubDate>Fri, 11 Nov 2011 12:49:25 +0100</pubDate>
            <guid isPermaLink="false">5409154</guid>        </item>
        <item>
            <title>Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=5409155&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq716486541576t16%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pituitary carcinoma occurs in ~0.2% of resected pituitary tumours and carries a poor prognosis (mean survival &amp;lt;4&amp;nbsp;years), with
 standard chemotherapy regimens showing limited efficacy. Recent evidence suggests that temozolomide (TMZ), an orally-active
 alkylating agent used principally in the management of glioblastoma, may also be effective in controlling aggressive/invasive
 pituitary adenomas/carcinomas. A low level of expression of the DNA-repair enzyme O6-methylguanine-DNA methyltransferase (MGMT)
 predicts TMZ responsiveness in glioblastomas, and a similar correlation has been observed in the majority of aggressive pituitary
 adenomas/carcinomas reported to date. Here, we report a case of a silent pituitary corticotroph adenoma, which subsequently
 re-prese...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409155</comments>
            <pubDate>Thu, 10 Nov 2011 16:52:57 +0100</pubDate>
            <guid isPermaLink="false">5409155</guid>        </item>
        <item>
            <title>Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide</title>
            <link>http://www.medworm.com/index.php?rid=5388079&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2245wm04g04j612%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To describe glucose status changes in patients with acromegaly receiving somatostatin analog lanreotide as primary treatment.
 This retrospective, single-center study conducted during 1996–2008, included acromegalic patients receiving primary lanreotide
 treatment. Baseline and last follow-up visit assessments included glucose status (according to American Diabetes Association
 criteria), growth hormone (GH), and insulin-like growth factor-1 (IGF-1) levels. Glucose control was considered improved when
 fasting plasma glucose or antidiabetic treatments were reduced, and deteriorated if fasting glucose was the same/higher but
 with increased antidiabetic treatments. 42 patients (median age 50&amp;nbsp;years; range 29–75&amp;nbsp;years) were included. At baseline, 26
 (62%) we...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388079</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:44 +0100</pubDate>
            <guid isPermaLink="false">5388079</guid>        </item>
        <item>
            <title>Endocrine changes after pediatric traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=5388081&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd6r88423436j0784%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Traumatic brain injury (TBI) is a very common occurrence in childhood, and can lead to devastating long term consequences.
 Recent research has focused on the potential endocrine consequences of TBI in adults. The research in children is less robust.
 This paper reviews current literature regarding TBI and possible hypothalamic and pituitary deficiencies in childhood. Acute
 endocrine changes are commonly found after TBI in pediatric patients, which can include changes in hypothalamic–pituitary–adrenal
 axis and antidiuretic hormone production and release. In the long term, both temporary and permanent alterations in pituitary
 function have been found. About 30% of children have hypopituitarism up to 5&amp;nbsp;years after injury. Growth hormone deficiency
 and disturb...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388081</comments>
            <pubDate>Fri, 04 Nov 2011 16:48:04 +0100</pubDate>
            <guid isPermaLink="false">5388081</guid>        </item>
        <item>
            <title>ACTH-secreting pituitary adenomas: size does not correlate with hormonal activity</title>
            <link>http://www.medworm.com/index.php?rid=5388080&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm624211x08224761%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;ACTH-secreting pituitary adenomas (Cushing’s disease, CD) are the most frequent cause of Cushing’s syndrome. To test whether
 the size of ACTH-secreting adenomas correlates with the degree of biochemical and clinical features of hypercortisolism, we
 retrospectively reviewed all newly diagnosed CD patients seen at our institution by two neuro-endocrinologists over a 10-year
 time period. We documented the number of clinical manifestations and baseline hormonal measurements. There were 37 microadenomas
 (μAs) and 16 macroadenomas (MAs). We sought to characterize the relationship between tumor size (μA vs. MA) and number of
 signs and symptoms of hypercortisolism and biochemical assessment of hypercortisolemia. There were no significant differences
 in mean age, BMI...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388080</comments>
            <pubDate>Fri, 04 Nov 2011 16:48:04 +0100</pubDate>
            <guid isPermaLink="false">5388080</guid>        </item>
        <item>
            <title>Aneurysmal subarachnoid hemorrhage (aSAH) results in low prevalence of neuro-endocrine dysfunction and NOT deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5361467&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flvq0t271mm403464%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neuro-endocrine deficiencies have been argued to be common sequelae after aneurysmal subarachnoid hemorrhage (aSAH). As this,
 however, does not resemble our clinical experience, we studied the incidence of neuro-endocrine and neuropsychological deficits
 after aSAH. Twenty-six patients (20 females) were prospectively screened for neuro-endocrine and neuropsychological deficits
 3, 6 and 12&amp;nbsp;months after aSAH. GH, IGF-1, prolactin, LH, FSH, estradiol, testosterone, ACTH as well as cortisol during ACTH-stimulation
 were assessed. Neuropsychological analysis covered verbal comprehension, short term and working memory, visuospatial construction,
 figural memory, psychomotor speed, attention, and concentration. During the study period 5 individuals demonstrated neuro-en...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361467</comments>
            <pubDate>Sat, 29 Oct 2011 05:41:37 +0100</pubDate>
            <guid isPermaLink="false">5361467</guid>        </item>
        <item>
            <title>The metabolic consequences of thyroxine replacement in adult hypopituitary patients</title>
            <link>http://www.medworm.com/index.php?rid=5361468&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F56212w63586503v2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The metabolic consequences of thyroxine replacement in patients with central hypothyroidism (CH) need to be evaluated. The
 aim was to examine the outcome of thyroxine replacement in CH. Adult hypopituitary patients (n&amp;nbsp;=&amp;nbsp;1595) with and without CH from KIMS (Pfizer International Metabolic Database) were studied before and after 2&amp;nbsp;years of
 GH replacement. CH patients (CH, n&amp;nbsp;=&amp;nbsp;1080) were compared with TSH sufficient patients (TSHsuff n&amp;nbsp;=&amp;nbsp;515) as one group and divided by thyroxine dose/kg/day into tertiles (CHlow-mid-high). Anthropometry, fasting glucose,
 glycosylated haemoglobin (HbA1c), blood pressure, lipids, IGF-I SDS, quality of life and morbidity were studied. Analyses
 were standardized for gender, age, number and types of pituita...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361468</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:30 +0100</pubDate>
            <guid isPermaLink="false">5361468</guid>        </item>
        <item>
            <title>Isolated GHD: investigation and implication of JAK/STAT related genes before and after rhGH treatment</title>
            <link>http://www.medworm.com/index.php?rid=5361470&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu78mt08337hj3608%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Isolated GH deficiency (IGHD) is a rare disorder that occurs as an idiopathic form in most cases. The pathway JAK/STAT promotes
 cellular growth and it could be implicated in this condition. In order to characterize IGHD in the pediatric population and
 identify genes differently expressed before and after GH therapy, we performed a quantitative evaluation of 84 genes related
 to the JAK/STAT pathway which, by promoting cellular growth. RT2 Profiler PCR Array and the other/subsequent evaluations were performed in three children with severe IGHD before and after
 6&amp;nbsp;months of GH therapy and in three matched normal children. Gene profiling was modified by the IGHD status and the GH therapy,
 with a modulation of GHR and some inflammatory genes such as CRP. We found a ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361470</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:28 +0100</pubDate>
            <guid isPermaLink="false">5361470</guid>        </item>
        <item>
            <title>Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5361469&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc759546685550527%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Giant (&amp;gt;4&amp;nbsp;cm) pituitary macroadenomas often require surgery to decompress the optic nerves. Compared with traditional open
 or transsphenoidal microscopic methods, the extended endoscopic endonasal transsphenoidal approach offers the potential for
 aggressive resection via a minimal access corridor. We conducted a systematic review of the literature to further our understanding
 of the role of endoscopy in the management of these challenging lesions. MEDLINE search of the modern literature (1995–2010)
 to identify surgical series for pediatric and adult pituitary adenomas &amp;gt;4&amp;nbsp;cm in maximal diameter. Patient and tumor characteristics,
 resection, morbidity and visual outcome were compared by approach. Chi-square and Fisher’s exact tests with post-hoc B...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361469</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:28 +0100</pubDate>
            <guid isPermaLink="false">5361469</guid>        </item>
        <item>
            <title>The anterior skull base nasal inventory (ASK nasal inventory): a clinical tool for evaluating rhinological outcomes after endonasal surgery for pituitary and cranial base lesions</title>
            <link>http://www.medworm.com/index.php?rid=5361472&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F379645712160p873%2F</link>
            <description>This study also suggests modifications to the instrument, which
 will serve as key quality of life endpoint in an ongoing multicenter nasal outcomes study.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s11102-011-0358-4Authors
		Andrew S. Little, Division of Neurosurgery, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, 2910 North 3rd Avenue, Phoenix, AZ 85013, USAHeidi Jahnke, Division of Neurosurgery, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, 2910 North 3rd Avenue, Phoenix, AZ 85013, USAPeter Nakaji, Division of Neurosurgery, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, 2910 North 3rd Avenue, Phoenix, AZ 85013, USAJohn Milligan, Arizona Otolaryngology Consultants, Phoenix, AZ 85016, USAKristi...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361472</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:27 +0100</pubDate>
            <guid isPermaLink="false">5361472</guid>        </item>
        <item>
            <title>Macrocorticotropinoma shrinkage and control of hypercortisolism under long-term cabergoline therapy: case report</title>
            <link>http://www.medworm.com/index.php?rid=5361471&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32352wm5p23015n8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cushing’s disease is the result of chronic overproduction of ACTH by a pituitary tumor. Although the optimal treatment is
 surgical removal of the adenoma, medical treatment might be an option in selected cases. A 40-year old woman with Cushing’s
 disease was treated with cabergoline, a neuromodulatory drug, for a corticotrophic macroadenoma. Treatment was initiated at
 a weekly dose of 0.5&amp;nbsp;mg and then, on the basis of the evolution of UFC values, adjusted until it reached 6&amp;nbsp;mg/week. With cabergoline
 treatment the patient was asymptomatic, the pituitary adenoma showed a significant shrinkage on MRI and urinary cortisol excretion
 remained within the normal range during 7&amp;nbsp;years. We show the effectiveness of cabergoline in maintaining long-term biochem...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361471</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:27 +0100</pubDate>
            <guid isPermaLink="false">5361471</guid>        </item>
        <item>
            <title>Prevalence of antipituitary antibodies in acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5324416&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F572t680k53432015%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Acromegaly is a rare disorder due to an excessive production of growth hormone (GH), typically caused by a GH-secreting pituitary
 adenoma. Anti-pituitary antibodies (APAs) are often seen in patients with different kinds of pituitary pathologies. Because
 GH has been proposed as a possible antigen recognized by such antibodies, the prevalence of APAs may be higher in conditions
 characterized by excessive GH secretion. The primary aim of this study was to compare the prevalence of APAs in patients with
 acromegaly and in controls with other types of pituitary tumors and healthy subjects. Secondary aim was to characterize the
 pituitary cells targeted by the APAs. Thirty eight acromegaly patients and 215 controls, including 38 patients with prolactinomas,
 64 with non-fu...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324416</comments>
            <pubDate>Fri, 14 Oct 2011 10:39:54 +0100</pubDate>
            <guid isPermaLink="false">5324416</guid>        </item>
        <item>
            <title>Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5315186&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F44hk814n75535052%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atherothrombosis is a multifactorial process, governed by an interaction between the vessel wall, hemodynamic factors and
 systemic atherothrombotic risk factors. Recent in vitro, human ex vivo and animal studies have implicated the hormone prolactin
 as an atherothrombotic mediator. To address this issue, we evaluated the anatomy and function of various microvascular beds
 as well as plasma atherothrombosis markers in patients with elevated prolactin levels. In this pilot study, involving 10 prolactinoma
 patients and 10 control subjects, sidestream dark field (SDF) imaging revealed a marked perturbation of the sublingual microcirculation
 in prolactinoma patients compared to control subjects, as attested to by significant changes in microvascular flow index (2.74&amp;nbsp...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315186</comments>
            <pubDate>Wed, 12 Oct 2011 16:06:58 +0100</pubDate>
            <guid isPermaLink="false">5315186</guid>        </item>
        <item>
            <title>Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery</title>
            <link>http://www.medworm.com/index.php?rid=5315187&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv049u8068m27587n%2F</link>
            <description>The objective of the current study was to determine a volumetric threshold for lesions with high perioperative morbidity and
 high rate of subtotal resection following endonasal endoscopic surgery. Thus, we analyzed a prospectively collected database
 of 71 patients who underwent endoscopic transsphenoidal approaches for macroadenomas (diameter &amp;gt;1&amp;nbsp;cm). Extend of resection
 (EOR) was calculated based on volumetric analysis of pre-and post-operative contrast-enhanced MRI. Average EOR was 97.8% and
 a gross total resection (GTR) was achieved in 76.1% of all patients. GTR was accomplished in 92.0% versus 38.1% of adenomas
 either without or with CS invasion, respectively. Likewise, GTR was accomplished in 90.2% versus 40.0% of lesions less than
 or greater then 10&amp;nbsp;cm3 respectively...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315187</comments>
            <pubDate>Tue, 11 Oct 2011 05:50:17 +0100</pubDate>
            <guid isPermaLink="false">5315187</guid>        </item>
        <item>
            <title>Sellar plasmacytomas: a concise review</title>
            <link>http://www.medworm.com/index.php?rid=5315188&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F73v0415nj4414502%2F</link>
            <description>We describe the management of these cases after the correct diagnosis was made and provide
 insight to preoperative diagnosis of this entity. Preoperative diagnosis may help avoid unnecessary surgical resection of
 an otherwise radiosensitive tumor. We also report and describe in detail a new case of sellar plasmacytoma that we have recently
 evaluated.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s11102-011-0352-xAuthors
		Rene Joukhadar, Department of Diabetes, Endocrinology, and Metabolism, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USAKen Chiu, Department of Diabetes, Endocrinology, and Metabolism, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA
	

	
		Journal PituitaryOnline ISSN 1573-7403Print ISSN 1386-3...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315188</comments>
            <pubDate>Mon, 10 Oct 2011 15:01:52 +0100</pubDate>
            <guid isPermaLink="false">5315188</guid>        </item>
        <item>
            <title>Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients</title>
            <link>http://www.medworm.com/index.php?rid=5286284&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvxp22165227r3870%2F</link>
            <description>In conclusion,
 discrepant GH and IGF-I levels in the diagnosis and follow-up of patients with acromegaly requires consideration of many factors
 that influence these parameters.
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s11102-011-0351-yAuthors
		Laura Boero, Departamento de Neuroendocrinología (Neuroendocrinology Department), Sociedad Argentina de Endocrinología y Metabolismo, Diaz Velez 3889, (1200), Buenos Aires, ArgentinaMarcos Manavela, Departamento de Neuroendocrinología (Neuroendocrinology Department), Sociedad Argentina de Endocrinología y Metabolismo, Diaz Velez 3889, (1200), Buenos Aires, ArgentinaKarina Danilowicz, Departamento de Neuroendocrinología (Neuroendocrinology Department), Sociedad Argentina de Endocrinología y Metabolismo, Diaz Velez 3889, (1200), B...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286284</comments>
            <pubDate>Fri, 30 Sep 2011 05:54:22 +0100</pubDate>
            <guid isPermaLink="false">5286284</guid>        </item>
        <item>
            <title>Acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature</title>
            <link>http://www.medworm.com/index.php?rid=5286285&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4pv5298t8405337r%2F</link>
            <description>We describe a 50-year-old female who presented with clinical signs and biochemical evidence
 of acromegaly. Pituitary MRI demonstrated a 2&amp;nbsp;mm hypointense lesion on the right side of the pituitary gland. However upon
 drilling of the upper clival bone to expose the sella during endoscopic transsphenoidal surgery, soft tumor-like tissue was
 encountered within the clivus. Exploration of the sella, including the area of hypointensity noted on preoperative imaging,
 did not identify any other abnormality. Immunohistochemical examination of the fully resected tumor demonstrated growth hormone
 immunoreactivity. Failed preoperative diagnosis of this rare ectopic GH-producing tumor was compounded by the presence of
 a misleading pituitary abnormality consistent with a microadenoma. The epide...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286285</comments>
            <pubDate>Fri, 30 Sep 2011 05:54:21 +0100</pubDate>
            <guid isPermaLink="false">5286285</guid>        </item>
        <item>
            <title>Radiotherapy for prolactin-secreting pituitary tumors</title>
            <link>http://www.medworm.com/index.php?rid=5274542&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr222247183k38447%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Review the medical and surgical management of patients with prolactinomas and provide an in-depth appraisal of the role of
 radiotherapy in the treatment of prolactinomas. A thorough review of the pertinent literature was carried out and relevant
 topics were identified. Topics covered in this comprehensive review include: indications for the use of radiotherapy, choice
 between conventional radiotherapy and stereotactic radiosurgery, as well as the benefits and potential complications associated
 with each modality. Due to the excellent response rates with medical management, and rapid symptom relief afforded by resection
 or debulking surgery in patients who do not respond or tolerate medical therapy, radiotherapy is reserved for patients who
 do not respond to dopami...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5274542</comments>
            <pubDate>Tue, 27 Sep 2011 05:46:12 +0100</pubDate>
            <guid isPermaLink="false">5274542</guid>        </item>
        <item>
            <title>Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery</title>
            <link>http://www.medworm.com/index.php?rid=5251232&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj314u355j754q722%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypothalamic obesity is a potential sequela of craniopharyngioma, arising from hypothalamic damage inflicted by either the
 tumor and/or its treatment. The marked weight gain that characterizes this disorder appears to result from impaired sympathoadrenal
 activation, parasympathetic dysregulation, and other hormonal and hypothalamic disturbances that upset the balance between
 energy intake and expenditure. Given hypopituitarism is commonly present, careful management of hormonal deficits is important
 for weight control in these patients. In addition, diet, exercise, and pharmacotherapy aimed at augmenting sympathetic output,
 controlling hyperinsulinism, and promoting weight loss have been used to treat this disease, but these measures rarely lead
 to sustained weigh...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5251232</comments>
            <pubDate>Wed, 21 Sep 2011 05:50:30 +0100</pubDate>
            <guid isPermaLink="false">5251232</guid>        </item>
        <item>
            <title>Pituitary tumor apoplexy in patients with Cushing’s disease: endocrinologic and visual outcomes after transsphenoidal surgery</title>
            <link>http://www.medworm.com/index.php?rid=5226799&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3p436621333j7502%2F</link>
            <description>We report four
 patients with Cushing’s disease harboring ACTH-secreting macroadenomas who presented with pituitary apoplexy. We report the
 endocrinologic and visual outcomes of these patients after emergent transsphenoidal surgery. A retrospective chart review
 was performed in 4 patients who presented with pituitary apoplexy from hemorrhage into an ACTH-secreting pituitary adenoma.
 The patient charts were reviewed for clinical presentation, neuroimaging findings, intraoperative surgical findings, pathologic
 findings, and postoperative endocrinologic and visual outcomes. All patients presented with acute headaches, nausea, vomiting,
 and visual loss from optic compression. MR imaging demonstrated a hemorrhagic macroadenoma that was confirmed at surgery.
 All patients underwent emerge...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226799</comments>
            <pubDate>Fri, 16 Sep 2011 16:49:48 +0100</pubDate>
            <guid isPermaLink="false">5226799</guid>        </item>
        <item>
            <title>Anti-VEGF therapy in pituitary carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5226800&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4ww0n86n3417m605%2F</link>
            <description>We report the case of a 44-year-old male patient with an aggressive silent corticotroph cell pituitary adenoma, subtype 2.
 In that it progressed to carcinoma despite temozolomide administration, anti-VEGF therapy was begun. MRI, PET scan and pathologic
 analysis were undertaken. After 10&amp;nbsp;months of anti-VEGF (bevacizumab) treatment no progression of the lesion was noted. The
 tumor was biopsied and morphological analysis showed severe cell injury, vascular abnormalities and fibrosis. Bevacizumab
 treatment has continued for additional 16&amp;nbsp;months to present with stabilization of disease as documented on serial MRI and
 PET scans. This is the first case of a bevacizumab-treated pituitary carcinoma with long-term, now 26&amp;nbsp;months, control of disease.
 The present findings are prom...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226800</comments>
            <pubDate>Thu, 15 Sep 2011 05:49:19 +0100</pubDate>
            <guid isPermaLink="false">5226800</guid>        </item>
        <item>
            <title>Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5226801&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr7j4342613x0j144%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To study the currently available data of recurrence rates of functioning and nonfunctioning pituitary adenomas following surgical
 cure and to analyze associated predisposing factors, which are not well established. A systematic literature search was conducted
 using Medline, Embase, Web of Science and the Cochran Library for studies reporting data on recurrence of pituitary adenoma
 after surgery, in nonfunctioning adenoma (NF), prolactinoma (PRL) acromegaly (ACRO) and Cushing’s disease (CUSH). Of 557 initially
 retrieved potential relevant studies 143 were selected. Recurrence in NFA was defined as reappearance of tumor on MRI or CT.
 Increase of hormone levels above normal limits as set by the authors after initial remission was used to indicate recurrence
 in the ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226801</comments>
            <pubDate>Wed, 14 Sep 2011 16:08:12 +0100</pubDate>
            <guid isPermaLink="false">5226801</guid>        </item>
        <item>
            <title>How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?</title>
            <link>http://www.medworm.com/index.php?rid=5209606&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6031681286n7v7w4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The optimal dosing of growth hormone (GH) therapy is challenging due to high inter-individual variability in subcutaneous
 GH absorption and sensitivity to the drug. Optimal dosing would maximize patient gains in height, body composition, and metabolic
 outcomes while minimizing GH adverse events. The pulsatile secretion of GH, however, does not allow direct assessment of circulating
 GH levels as a measure of response to GH therapy. Insulin-like growth factor (IGF-I), a key marker of GH activity, has been
 shown to be useful in monitoring and adjusting GH dose during treatment of GH deficiency (GHD). Traditionally, monitoring
 IGF-I levels in response to GH therapy has been recommended for assessment of treatment compliance and safety. More recently,
 GH treatment guid...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209606</comments>
            <pubDate>Sat, 10 Sep 2011 15:48:32 +0100</pubDate>
            <guid isPermaLink="false">5209606</guid>        </item>
        <item>
            <title>The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5209607&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6m8mh262890426gg%2F</link>
            <description>In this study a substitution strategy
 of hydrocortisone guided by the postoperative cortisol response to CRH appeared safe and did not result in any case of adrenal
 crises. However, the early postoperative CRH-test does not reliably predict adrenal function after TS for pituitary adenomas
 in all patients and retesting is mandatory.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s11102-011-0344-xAuthors
		Nieke E. Kokshoorn, Department of Endocrinology and Metabolic Diseases C4-R, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The NetherlandsJohannes A. Romijn, Department of Endocrinology and Metabolic Diseases C4-R, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The NetherlandsFerdinand Roelfsema, Department of Endocrinology and Metabolic Disea...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209607</comments>
            <pubDate>Fri, 09 Sep 2011 05:45:52 +0100</pubDate>
            <guid isPermaLink="false">5209607</guid>        </item>
        <item>
            <title>Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5162750&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd41g5j444u711301%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Long-acting somatostatin analogs are frequently used as adjuvant treatment of acromegaly patients after noncurative surgery.
 This sudy aims to compare the efficacy of octreotide long-acting release (OCT) and lanreotide Autogel (LAN) in acromegaly
 patients. Sixty-eight patients not cured by transsphenoidal endoscopic or microscopic pituitary surgery between 2003 and 2009
 were retrospectively analyzed (25 men; 43 women; mean age 41.1&amp;nbsp;±&amp;nbsp;10.9&amp;nbsp;years [range 18–65&amp;nbsp;years]). The patients were assigned
 randomly to OCT (n&amp;nbsp;=&amp;nbsp;36) and LAN (n&amp;nbsp;=&amp;nbsp;32) groups. Evaluations included insulin-like growth factor I (IGF-I) and growth hormone
 (GH) after oral glucose tolerance test (OGTT) 3, 6, 12 and 18&amp;nbsp;months after starting medical treatment;...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162750</comments>
            <pubDate>Tue, 23 Aug 2011 15:53:08 +0100</pubDate>
            <guid isPermaLink="false">5162750</guid>        </item>
        <item>
            <title>Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis</title>
            <link>http://www.medworm.com/index.php?rid=5162751&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4jp001617k151637%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypophysitis is a chronic inflammation of the pituitary gland often caused by autoimmunity. Among the autoimmune diseases
 it is one of the few where the autoantigens remain to be identified. The goal of the paper was to characterize the antigenic
 profile in a previously reported patient with IgG4-related hypophysitis. Immunofluorescence and immunoblotting were performed
 to detect antibodies to human pituitary proteins. The proteins recognized by western blotting were then submitted to mass
 spectrometry for sequencing. The patient’s autoantibodies recognized two unique bands around 40 and 30&amp;nbsp;kDa on immunoblotting.
 Sequencing revealed one peptide from proopiomelanocortin in the 40&amp;nbsp;kDa band and four peptides from growth hormone in the 30&amp;nbsp;kDa
 band. Th...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162751</comments>
            <pubDate>Mon, 22 Aug 2011 16:00:02 +0100</pubDate>
            <guid isPermaLink="false">5162751</guid>        </item>
        <item>
            <title>New targeted therapies in pituitary carcinoma resistant to temozolomide</title>
            <link>http://www.medworm.com/index.php?rid=5162752&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk2747nx3km286477%2F</link>
            <description>We described the tumoral effects
 of a combination therapy with everolimus (5&amp;nbsp;mg/day) and octreotide (30&amp;nbsp;mg/month) and the mTOR signalling expression in a patient
 with pituitary ACTH carcinoma, compared to 17 other ACTH adenomas. Clinical and biochemical evaluation were performed every
 month, and imaging after 3&amp;nbsp;month of treatment. mTOR signaling was assessed by microarray expression analysis of each of the
 18 adenoma tissues. Combined therapy failed to control pituitary tumor growth and ACTH secretion. Slight activation of mTOR
 signaling was found in all ACTH tumors alongside important variations between tumors. Low antitumor efficacy shown by everolimus
 might be explained by the weak activation of mTOR pathway in ACTH tumors. Everolimus treatment was inefficient at co...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162752</comments>
            <pubDate>Sat, 20 Aug 2011 15:51:02 +0100</pubDate>
            <guid isPermaLink="false">5162752</guid>        </item>
        <item>
            <title>Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5162753&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh84h4jwv207x4692%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We aimed at the evaluation of MEG3 and GADD45γ expression in sporadic functioning and clinically non-functioning human pituitary adenomas, morphologically characterized
 by immunohistochemistry analysis and their association with clinical features. Thirty eight patients who had undergone hypophysectomy
 at São José Hospital of Irmandade Santa Casa de Misericórdia in Porto Alegre, Brazil, were included in this study. We evaluated
 tumor-type specific MEG3 and GADD45γ expression by qRT-PCR in the pituitary adenomas, and its association with clinical features, as age, gender and tumor size,
 obtained from medical records. The patients consisted of 21 males and 17 females and the mean age was 47&amp;nbsp;±&amp;nbsp;14 (mean&amp;nbsp;±&amp;nbsp;SD),
 ranging from 18 to 73&amp;nbsp;years-...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162753</comments>
            <pubDate>Thu, 18 Aug 2011 06:02:56 +0100</pubDate>
            <guid isPermaLink="false">5162753</guid>        </item>
        <item>
            <title>A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas</title>
            <link>http://www.medworm.com/index.php?rid=5162754&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F850j767021561735%2F</link>
            <description>In conclusion, patients with prolactinomas treated with either CBG
 or BRC showed higher prevalence of trace and mild Tri or Mi regurgitation, but these findings were not clinically significant.
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s11102-011-0339-7Authors
		Cesar Luiz Boguszewski, SEMPR, Serviço de Endocrinologia e Metabologia do Hospital de Clínicas, Department of Internal Medicine, Federal University of Parana, Avenida Agostinho Leao Junior, 285, Curitiba, PR 80030-110, BrazilCarlos Mauricio Correa dos Santos, SEMPR, Serviço de Endocrinologia e Metabologia do Hospital de Clínicas, Department of Internal Medicine, Federal University of Parana, Avenida Agostinho Leao Junior, 285, Curitiba, PR 80030-110, BrazilKelly Suga Sakamoto, SEMPR, Serviço de Endocrinologia e Me...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5162754</comments>
            <pubDate>Wed, 17 Aug 2011 05:55:39 +0100</pubDate>
            <guid isPermaLink="false">5162754</guid>        </item>
        <item>
            <title>The pituitary stalk transection syndrome: multifaceted presentation in adulthood</title>
            <link>http://www.medworm.com/index.php?rid=5126804&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5353846344144558%2F</link>
            <description>We present 4 cases of
 stalk transection syndrome diagnosed by the adult endocrinologist that reflect its pleiotropic manifestations. In all cases,
 MRI showed pathognomonic findings with small anterior pituitary, diminutive or absent infundibulum and ectopic posterior pituitary
 at the median eminence. Clinical presentation occurred in childhood or the second decade of life. The hormonal deficits were
 variable in severity and onset, with adrenal insufficiency diagnosed in the second and forth decade in three patients, and
 absent in another. Growth hormone deficiency was diagnosed before age 10 in three cases and at age 20 in one case with normal
 spontaneous linear growth. Hypothyroidism had onset in the first or second decade of life and hypogonadism was diagnosed during
 work-up for l...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5126804</comments>
            <pubDate>Mon, 08 Aug 2011 19:53:14 +0100</pubDate>
            <guid isPermaLink="false">5126804</guid>        </item>
        <item>
            <title>An unusual association of neuroendocrine tumors in MEN 1A</title>
            <link>http://www.medworm.com/index.php?rid=5110248&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft4720ru268626538%2F</link>
            <description>This report represents an unusual case of MEN 1A with association of insulinomas, gastrinomas
 glucagonomas and somatostatinomas in the same patient.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s11102-011-0334-zAuthors
		Mariela Varsavsky, Bone Metabolic Unit, Endocrinology Department, Hospital Universitario San Cecilio, Av. Dr. Oloriz 16, 18012 Granada, SpainRebeca Reyes-García, Bone Metabolic Unit, Endocrinology Department, Hospital Universitario San Cecilio, Av. Dr. Oloriz 16, 18012 Granada, SpainGuillermo Alonso García, Bone Metabolic Unit, Endocrinology Department, Hospital Universitario San Cecilio, Av. Dr. Oloriz 16, 18012 Granada, SpainManuel Muñoz-Torres, Bone Metabolic Unit, Endocrinology Department, Hospital Universitario San Cecilio, Av. Dr. Oloriz 16, 18012 Granad...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5110248</comments>
            <pubDate>Thu, 04 Aug 2011 15:33:08 +0100</pubDate>
            <guid isPermaLink="false">5110248</guid>        </item>
        <item>
            <title>Pituitary blastoma: a unique embryonal tumor</title>
            <link>http://www.medworm.com/index.php?rid=5088988&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq853174743441j68%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pituitary blastoma, a recently described tumor of the neonatal pituitary, exhibits differentiation to Rathke epithelium and
 adenohypophysial cells of folliculostellate and secretory type, a reflection of arrested pituitary development and unchecked
 proliferation (Scheithauer et al. in Acta Neuropathol 116(6):657–666, 2008). Herein, we report the pathologic features of three additional cases, all ACTH-producing. One involved a 9-month-old male
 presenting with progressive right ophthalmoplegia, MRI findings of a large suprasellar mass with cavernous sinus invasion,
 and elevated plasma ACTH levels. The second was nonfunctioning and occurred in a 13-month-old female with right third nerve
 palsy. The third had been previously published as a “pituitary adenoma” in ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5088988</comments>
            <pubDate>Fri, 29 Jul 2011 16:04:50 +0100</pubDate>
            <guid isPermaLink="false">5088988</guid>        </item>
        <item>
            <title>Primary hypothyroidism presenting as pseudoacromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5088989&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0314836r6p602126%2F</link>
            <description>We report an unusual presentation of primary hypothyroidism with
 pseudoacromegaly and thyrotroph hyperplasia mimicking a pituitary macroadenoma. The thyrotroph hyperplasia resolved completely
 with levothyroxine therapy.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s11102-011-0336-xAuthors
		K. V. S. Hari Kumar, Department of Endocrinology, Command Hospital, Lucknow, UP 226002, IndiaAltamash Shaikh, Department of Endocrinology, PD Hinduja National Hospital and Medical Research Centre, Mahim, Mumbai, 400016 IndiaIrfan Anwar, Department of Neurosurgery, Command Hospital, Lucknow, UP 226002, IndiaP. Prusty, Department of Endocrinology, Command Hospital, Lucknow, UP 226002, India
	

	
		Journal PituitaryOnline ISSN 1573-7403Print ISSN 1386-341X (Source: Pituitary)</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5088989</comments>
            <pubDate>Fri, 29 Jul 2011 16:04:48 +0100</pubDate>
            <guid isPermaLink="false">5088989</guid>        </item>
        <item>
            <title>Pregnancy and acromegaly: a review</title>
            <link>http://www.medworm.com/index.php?rid=5070465&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe9216931x7tuht4m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To review the literature regarding the diagnosis and management of acromegaly during pregnancy. A systematic literature search
 was performed using MEDLINE including hand-searching reference lists from original articles. The diagnosis of acromegaly during
 pregnancy is made difficult due to the physiologic changes in pituitary GH secretion and IGF-1 production resulting from placental
 GH secretion and the inability of commercial assays to discriminate between pituitary and placental GH. Most patients with
 acromegaly during pregnancy do not have an increase in tumor size, metabolic complications are uncommon, and neonatal outcome
 is largely unaffected. IGF-1 levels tend to be stable in such patients possibly due to the high estrogen levels causing GH
 resistance. Dopa...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5070465</comments>
            <pubDate>Mon, 25 Jul 2011 15:45:36 +0100</pubDate>
            <guid isPermaLink="false">5070465</guid>        </item>
        <item>
            <title>Serum adipokines and low density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5064099&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj6555l3347716822%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim was to evaluate the concentrations of lipid subfractions in relation to adipokines and metabolic parameters in adult
 growth hormone (GH)-deficient hypopituitary patients on conventional replacement therapy. The study included 21 GH deficient-hypopituitary
 patients (age: 36.0&amp;nbsp;±&amp;nbsp;15.1&amp;nbsp;years, male/female: 7/14) on conventional replacement therapy other than GH and 20 comparable controls
 (age: 37.3&amp;nbsp;±&amp;nbsp;14.0&amp;nbsp;years, male/female: 6/14). Lipid subfractions (Lipoprint system), serum adipokine (leptin, adiponectin,
 resistin) concentrations, body composition, a surrogate marker for insulin resistance (HOMA) and conventional lipid profile
 were evaluated. No statistically significant difference was found with respect to HOMA, adipokine conce...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064099</comments>
            <pubDate>Thu, 21 Jul 2011 18:06:33 +0100</pubDate>
            <guid isPermaLink="false">5064099</guid>        </item>
        <item>
            <title>Immediate and delayed postoperative morbidity in functional and non-functioning pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5064100&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1u7463207r16814%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurosurgery is the most widely used definite treatment for pituitary tumors, while medical treatments are a good option to
 improve symptoms, which tend to recur when drugs are stopped. The aim of this study was to assess postsurgical morbidity of
 secreting pituitary adenomas (adrenocorticotropin hormone –ACTH- and growth hormone –GH- secreting) and non-functioning (NF)
 adenomas, operated between January 2002 and May 2009. We retrospectively reviewed the data of 94 patients who were operated
 by the same neurosurgeons and compared the immediate (1st month) and delayed (1st year) complications between the three groups
 of adenomas. Forty had immediate post-operative complications (42% of NF, 37% of GH-secreting and 48% of ACTH-secreting adenomas).
 The most freque...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064100</comments>
            <pubDate>Thu, 21 Jul 2011 18:06:32 +0100</pubDate>
            <guid isPermaLink="false">5064100</guid>        </item>
        <item>
            <title>Cushing’s syndrome: diagnosis and surveillance using salivary cortisol</title>
            <link>http://www.medworm.com/index.php?rid=5064101&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhw603m6424k275p2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This short review summarizes the use of late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome, in
 the evaluation of patients with adrenal incidentalomas, and in monitoring of post-operative patients, with a focus on the
 different assay methodologies currently in common use. The focus is on recent studies identified by literature searches using
 Ovid Medline and Google Scholar as well as analysis of several recent review articles on the topic. Measurement of late night
 salivary cortisol (LNSC) has an excellent sensitivity and specificity for the diagnosis of Cushing’s syndrome regardless of
 the assay methodology used. Immunoassays have the advantage of simplicity, low cost, and small sample volume requirement,
 while liquid chromatograph...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064101</comments>
            <pubDate>Thu, 21 Jul 2011 18:06:31 +0100</pubDate>
            <guid isPermaLink="false">5064101</guid>        </item>
        <item>
            <title>The growth hormone receptor polymorphism in patients with acromegaly: relationship to BMI and glucose metabolism</title>
            <link>http://www.medworm.com/index.php?rid=5031057&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F05488np82j19t04h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study was to investigate association between the frequencies of Growth Hormone receptor (d3GHR) gene polymorphisms
 and some clinical parameters of acromegalic patients. Total of 35 acromegalic patients were enrolled to study. The d3GHR polymorphism
 was identified by using polymerase chain reaction from peripheral blood samples. The levels of systolic and diastolic blood
 pressure, BMI, fasting plasma glucose (FPG), Fasting insulin, HOMA-IR, IGF-I, GH, IGFBP3, triglyceride, HDL and LDL cholesterol
 concentrations were evaluated. The frequencies of d3GHR genotypes were found as follows; 5 (14.3%) subjects had d3/d3, 11
 (31.4%) had d3/fl and 19 (54.3%) had fl/fl in patients. The prevalence of the d3 and fl alleles was 30 and 70%, respectively.
 Systolic ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031057</comments>
            <pubDate>Sun, 10 Jul 2011 05:49:40 +0100</pubDate>
            <guid isPermaLink="false">5031057</guid>        </item>
        <item>
            <title>Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation</title>
            <link>http://www.medworm.com/index.php?rid=5021461&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fht3711p301gw6527%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 39-year-old woman with autosomal dominant polycystic kidney disease (ADPKD) presented with acromegaly and a pituitary macroadenoma.
 There was a family history of this renal disorder. She had undergone surgery for pituitary adenoma 6&amp;nbsp;years prior. Physical
 examination disclosed bitemporal hemianopsia and elevation of both basal growth hormone (GH) 106&amp;nbsp;ng/mL (normal 0–5) and insulin-like
 growth factor (IGF-1) 811&amp;nbsp;ng/mL (normal 48–255) blood levels. A magnetic resonance imaging scan disclosed a 3.0&amp;nbsp;cm sellar
 and suprasellar mass with both optic chiasm compression and left cavernous sinus invasion. Pathologic, cytogenetic, molecular
 and in silico analysis was undertaken. Histologic, immunohistochemical and ultrastructural studies of the lesion ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021461</comments>
            <pubDate>Sat, 09 Jul 2011 06:18:50 +0100</pubDate>
            <guid isPermaLink="false">5021461</guid>        </item>
        <item>
            <title>Cognitive function in acromegaly: description and brain volumetric correlates</title>
            <link>http://www.medworm.com/index.php?rid=5021463&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0802871p81324615%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In acromegaly, we reported on increased rates of affective disorders such as dysthymia and depression, as well as structural
 brain changes. Objective of this study was to determine if cognitive impairments in patients with acromegaly exist and whether
 such impairments are associated with structural brain alterations defined by magnetic resonance imaging (MRI). In this cross-sectional
 study, 55 patients with biochemically confirmed acromegaly were enrolled. MRI data were compared with 87 control subjects.
 Main outcome measures were performance levels in 13 cognitive tests covering the domains of attention, memory and executive
 function, with performance below the cut-off level of the 16th percentile rated as impaired. In addition, individual global
 and hippocampal ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021463</comments>
            <pubDate>Thu, 07 Jul 2011 05:42:40 +0100</pubDate>
            <guid isPermaLink="false">5021463</guid>        </item>
        <item>
            <title>Procalcitonin can be used as a marker of premature atherosclerosis in acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5021462&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq34678784x5871u3%2F</link>
            <description>The objective of the study was to evaluate arterial morphologic changes of early atherosclerosis and changes in procalcitonin
 (PCT) levels in patients with acromegaly according to disease activity. Thirty-three active and 20 inactive acromegaly patients
 followed at Endocrinology-Metabolism out-patient clinic of Cerrahpasa Medical Faculty between 2004 and 2008 were included
 in the study. Twenty gender and age matched healthy subjects were included as the control group. Intima-media thickness (IMT)
 of the carotid arteries was measured by ultrasonography. Blood was drawn for biochemical tests and the serum concentrations
 of C-reactive protein (CRP) and PCT. Intergroup analysis revealed no significant differences between Growth hormone (GH),
 insulin like growth factor-1 (IGF-1), and IMT ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021462</comments>
            <pubDate>Thu, 07 Jul 2011 05:42:40 +0100</pubDate>
            <guid isPermaLink="false">5021462</guid>        </item>
        <item>
            <title>Improvement of cardiac parameters in patients with acromegaly treated with medical therapies</title>
            <link>http://www.medworm.com/index.php?rid=4994061&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F54kg72tm03032l41%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In acromegaly, growth hormone (GH) and insulin-like growth factor-1 (IGF-1) excess results in a specific cardiomyopathy characterized
 by concentric cardiac hypertrophy primarily associated with diastolic dysfunction that can lead to impaired systolic function
 and eventually heart failure. This review of the literature evaluates the effect of therapeutic intervention on cardiac parameters.
 Clinical studies investigating the impact of treatments for acromegaly on cardiac function published between January 1980
 and January 2009 were identified through electronic searches of Medline. Suppression of GH and IGF-1 following surgery or
 medical treatment with somatostatin analogue therapy is effective in decreasing left ventricular (LV) hypertrophy, with subsequent
 improve...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4994061</comments>
            <pubDate>Tue, 28 Jun 2011 15:51:54 +0100</pubDate>
            <guid isPermaLink="false">4994061</guid>        </item>
        <item>
            <title>Can cardiac surgery cause hypopituitarism?</title>
            <link>http://www.medworm.com/index.php?rid=4970913&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn20636l056542786%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Apoplexy of pituitary adenomas with subsequent hypopituitarism is a rare but well recognized complication following cardiac
 surgery. The nature of cardiac on-pump surgery provides a risk of damage to the pituitary because the vascular supply of the
 pituitary is not included in the cerebral autoregulation. Thus, pituitary tissue may exhibit an increased susceptibility to
 hypoperfusion, ischemia or intraoperative embolism. After on-pump procedures, patients often present with physical and psychosocial
 impairments which resemble symptoms of hypopituitarism. Therefore, we analyzed whether on-pump cardiac surgery may cause pituitary
 dysfunction also in the absence of pre-existing pituitary disease. Twenty-five patients were examined 3–12&amp;nbsp;months after on-pump
 car...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4970913</comments>
            <pubDate>Fri, 24 Jun 2011 16:03:31 +0100</pubDate>
            <guid isPermaLink="false">4970913</guid>        </item>
        <item>
            <title>Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4970914&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F38j3u73175427473%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been reported that women with prolactinoma were exposed, early in life, to an environment characterized by an absent
 or violent father. The present study was designed to evaluate whether paternal absence or violent paternal behavior were more
 prevalent in patients with pituitary adenomas (prolactinoma, acromegaly, non-secreting adenoma and Cushing’s disease) compared
 to a control population. We conducted an observational case–control multicenter study. We interviewed 395 patients with prolactinoma
 (296 females and 99 males), 130 with acromegaly (87 females and 43 males), 237 with non-secreting adenoma (144 females and
 93 males) and 68 with Cushing’s disease (61 females and 7 males) and 365 patients from the same clinics with nodular thyroid
 disease or...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4970914</comments>
            <pubDate>Thu, 23 Jun 2011 16:27:27 +0100</pubDate>
            <guid isPermaLink="false">4970914</guid>        </item>
        <item>
            <title>Erratum to: An endoscopic modification of the simultaneous ‘above and below’ approach to large pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4970915&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft444110g3552q2mr%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s11102-011-0323-2Authors
		Gilberto Ka Kit Leung, Division of Neurosurgery, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, People’s Republic of ChinaMichele Mae Ann Yuen, Division of Endocrinology and Metabolism, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, People’s Republic of ChinaWing Sun Chow, Division of Endocrinology and Metabolism, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, People’s Republic of ChinaPhilip Yat Hang Tse, Division of Neurosurgery, Department of Surgery, Li Ka Shing Faculty of Med...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4970915</comments>
            <pubDate>Thu, 23 Jun 2011 16:27:26 +0100</pubDate>
            <guid isPermaLink="false">4970915</guid>        </item>
        <item>
            <title>Ectopic posterior pituitary and stalk abnormality predicts severity and coexisting hormone deficiencies in patients with congenital growth hormone deficiency</title>
            <link>http://www.medworm.com/index.php?rid=4938311&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F265288j7v35uq060%2F</link>
            <description>This study emphasizes a significant clinico-radiological correlation in Asian Indian GHD patients.
 MRI abnormalities in the hypothalamic pituitary area, especially EPP/PSA are more common in patients with CPHD and severe
 GHD. Among CPHD, EPP/PSA predicts association with hypothyroidism or hypocortisolism. IGHD with MRI abnormality may evolve
 into CPHD.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s11102-011-0321-4Authors
		Varsha S. Jagtap, Department of Endocrinology, Seth G S Medical College, Parel, Mumbai, Maharashtra 400012, IndiaShrikrishna V. Acharya, Department of Endocrinology, Seth G S Medical College, Parel, Mumbai, Maharashtra 400012, IndiaVijaya Sarathi, Department of Endocrinology, Seth G S Medical College, Parel, Mumbai, Maharashtra 400012, IndiaAnurag R. Lila, De...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938311</comments>
            <pubDate>Sat, 11 Jun 2011 06:37:34 +0100</pubDate>
            <guid isPermaLink="false">4938311</guid>        </item>
        <item>
            <title>Be careful …. She has a pituitary gland in her nose</title>
            <link>http://www.medworm.com/index.php?rid=4938312&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm37h0m04676j8350%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In this case report we describe a 38 year-old-female with galactorrhea several months after the birth of an anencephalic child.
 She had hyperpolactemia and imaging of the pituitary gland revealed a midline defect and a nasopharyngeal mass compatible
 with a meningo-(hypophyso-) encephalocele and possibly an ectopic teratoma or desmoid. She was treated with dopamine agonists
 for 10&amp;nbsp;years and after cessation of therapy her prolactin levels remain normal. The nasopharyngeal mass remained unchanged
 over time and there were no signs of hypopituitarism. The hyperprolactinemia at presentation was probably caused by earlier
 pregnancy and stalk dysfunction due to traction by the mass. With decline of pituitary size, after starting dopamine agonists,
 the traction probab...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938312</comments>
            <pubDate>Fri, 10 Jun 2011 06:34:18 +0100</pubDate>
            <guid isPermaLink="false">4938312</guid>        </item>
        <item>
            <title>An endoscopic modification of the simultaneous ‘above and below’ approach to large pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4904535&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqq80706714204175%2F</link>
            <description>We present two
 patients successfully treated with this approach. Complete tumor removal was achieved and both patients achieved satisfactory
 functional recovery.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s11102-011-0319-yAuthors
		Gilberto Ka Kit Leung, Division of Neurosurgery, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, People’s Republic of ChinaMichelle Mae Ann Yuen, Division of Endocrinology and Metabolism, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, People’s Republic of ChinaWing Sun Chow, Division of Endocrinology and Metabolism, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4904535</comments>
            <pubDate>Fri, 03 Jun 2011 05:59:46 +0100</pubDate>
            <guid isPermaLink="false">4904535</guid>        </item>
        <item>
            <title>Clinical, quality of life, and economic value of acromegaly disease control</title>
            <link>http://www.medworm.com/index.php?rid=4854689&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp61132406616h510%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although acromegaly is a rare disease, the clinical, economic and health-related quality of life (HRQoL) burden is considerable
 due to the broad spectrum of comorbidities as well as the need for lifelong management. We performed a comprehensive literature
 review of the past 12&amp;nbsp;years (1998–2010) to determine the benefit of disease control (defined as a growth hormone [GH] concentration
 &amp;lt;2.5&amp;nbsp;μg/l and insulin-like growth factor [IGF]-1 normal for age) on clinical, HRQoL, and economic outcomes. Increased GH and
 IGF-1 levels and low frequency of somatostatin analogue use directly predicted increased mortality risk. Clinical outcome
 measures that may improve with disease control include joint articular cartilage thickness, vertebral fractures, left ventri...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854689</comments>
            <pubDate>Thu, 19 May 2011 16:34:54 +0100</pubDate>
            <guid isPermaLink="false">4854689</guid>        </item>
        <item>
            <title>Pituicytoma: overview of treatment strategies and outcome</title>
            <link>http://www.medworm.com/index.php?rid=4854690&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn44k385356565231%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pituicytoma is an extremely rare and little-studied primary tumour of the adult neurohypophysis. With total resection,
 the pituicytoma appears to have a good prognosis. However, its highly vascular nature makes total resection difficult and
 local recurrence after subtotal resection is not uncommon. To date, only 40 cases of pituicytoma have been reported in literature.
 In addition to our own case of a suprasellar pituicytoma, we are reviewing and discussing these with particular attention
 paid on the surgical management and outcome of this rare neoplasm.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s11102-011-0317-0Authors
		Ariyan Pirayesh Islamian, International Neuroscience Institute, Rudolf Pichlmayr Str. 4, 30625 Hannover, GermanyRolf Buslei, Path...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854690</comments>
            <pubDate>Thu, 19 May 2011 16:34:52 +0100</pubDate>
            <guid isPermaLink="false">4854690</guid>        </item>
        <item>
            <title>Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4854691&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6m8768704k761421%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Clinically non-functioning pituitary adenomas account for about one-third of pituitary tumors. The majority of them are pathologically
 classified as gonadotropinomas or null-cell adenomas without hormonal expression. The rest represent silent corticotroph adenomas
 and plurihormonal tumors. Conservative therapy with dopamine agonists is effective in some cases only depending on the expression
 of dopamine 2 receptors (D2R). The aim of this study was to quantitatively estimate D2R expression in clinically non-functioning
 pituitary adenomas and correlate the results with adenoma type according to pathological classification. Out of the 87 adenomas
 investigated, 63 expressed gonadotropins, 7 were silent corticotroph adenomas, 7 were plurihormonal tumors, and only 6 did
...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854691</comments>
            <pubDate>Thu, 19 May 2011 16:34:51 +0100</pubDate>
            <guid isPermaLink="false">4854691</guid>        </item>
        <item>
            <title>Medical suppression of hypercortisolemia in Cushing’s syndrome with particular consideration of etomidate</title>
            <link>http://www.medworm.com/index.php?rid=4822502&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd42v416l278073m4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cushing’s syndrome is associated with excessive cortisol secretion by the adrenal gland or ectopic tumours and may result
 in diabetes, hypertension, and life-threatening infections with high mortality rates especially in the case of surgical resection.
 Although surgical resection is the treatment of choice, patients may benefit from preceding medical therapy. This may especially
 be useful as an adjunctive approach in emergency settings, if patients cannot undergo surgery, if surgery or radiotherapy
 fails, or if the tumour recurs. Medical therapy can be categorized in three different groups—inhibition of steroidogenesis,
 suppression of adrenocorticotropic hormone, and antagonism of the glucocorticoid receptor. However, the majority of common
 drugs are not avail...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822502</comments>
            <pubDate>Tue, 10 May 2011 06:03:19 +0100</pubDate>
            <guid isPermaLink="false">4822502</guid>        </item>
        <item>
            <title>Acute cortisol release during stereotactic fractionated radiotherapy to an ACTH-secreting pituitary macroadenoma</title>
            <link>http://www.medworm.com/index.php?rid=4822503&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv64r3w5mu8734516%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 33-year old male was diagnosed with Cushing’s disease due to a large and invasive ACTH-secreting macroadenoma. After surgical
 failure ketoconazole therapy was initiated to control cortisol hypersecretion and his symptoms. He was referred to radiotherapy,
 and fractionated stereotactic radiotherapy in 30 fractions was delivered. After 12 daily fractions of radiotherapy the urinary
 cortisol release increased abruptly together with clinical deterioration. The daily ketoconazole dose was increased, and 10&amp;nbsp;days
 after concluding radiotherapy his urinary cortisol returned to normal values. Hormonal remission was observed less than 1&amp;nbsp;year
 following radiotherapy.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s11102-011-0315-2Authors
		I. Shimon, Institu...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822503</comments>
            <pubDate>Tue, 10 May 2011 06:03:17 +0100</pubDate>
            <guid isPermaLink="false">4822503</guid>        </item>
        <item>
            <title>Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience</title>
            <link>http://www.medworm.com/index.php?rid=4806631&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh55p3j150m612k15%2F</link>
            <description>The objective of this study is to assess the secretory pattern of GH after Oral Glucose Tolerance Test (OGTT) or day-curve
 (DC), in relation with IGF-I and to evaluate the influence of therapy on OGTT. A retrospective analysis in 279 OGTTs performed
 in 93 acromegalic patients in our unit from January 1988 to December 2005, in 77 patients also DC data were retrived. GH concentration
 was evaluated by 3 different systems (RIA, IRMA and chemiluminescence assays), and IGF-I by two RIAs. About 12% of OGTT samples
 were discordant with the baseline, while discordance between nadir and 120th minute was much lower (5%), with all discordant
 values, except one, near the cut-off lines. Correlation between DC and OGTT data was around 0.99 among all values, discordance
 rate between nadir and minimu...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4806631</comments>
            <pubDate>Wed, 04 May 2011 14:51:45 +0100</pubDate>
            <guid isPermaLink="false">4806631</guid>        </item>
        <item>
            <title>Cavernous sinus apoplexy presenting isolated sixth cranial nerve palsy: case report</title>
            <link>http://www.medworm.com/index.php?rid=4745284&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbr574k54381qj877%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The clinical and radiological findings of a patient affected by apoplexy of an adenoma located within cavernous sinus and
 presenting isolated Cranial Nerve (CN) VI palsy are reported. The differential diagnosis with other pathologies is debated,
 and pathogenesis of isolated abducens nerve palsy is investigated. The pertinent literature of this uncommon case of apoplexy
 is reviewed. A 59-year-old female presented sudden appearance of CN VI palsy associated to violent headache. Endocrinological
 assessment did not show pituitary insufficiency; MRI depicted an adenoma located within the left CS. She underwent an endoscopic
 endonasal procedure with extensive opening of the cavernous sinus, occupied by an ischemic adenoma. Afterward, neurological
 symptoms promptly resol...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745284</comments>
            <pubDate>Tue, 19 Apr 2011 07:15:56 +0100</pubDate>
            <guid isPermaLink="false">4745284</guid>        </item>
        <item>
            <title>Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data</title>
            <link>http://www.medworm.com/index.php?rid=4745283&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk36n327g2j002774%2F</link>
            <description>In conclusions, polycythemia can be a direct, albeit rare, secondary manifestation of acromegaly,
 that must be considered during the diagnostic work-up of acromegalic patients presenting with such disorder.
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s11102-011-0311-6Authors
		Gabriele Zoppoli, Department of Internal Medicine, University of Genoa, Genoa, ItalyFederico Bianchi, Department of Endocrine and Medical Sciences and Center of Excellence for Biomedical Research, University of Genoa, Viale Benedetto XV, 6, 16132 Genoa, ItalyAndrea Bruzzone, Department of Internal Medicine, University of Genoa, Genoa, ItalyAlessandro Calvia, Department of Internal Medicine, University of Genoa, Genoa, ItalyCaterina Oneto, Department of Internal Medicine, University of Genoa, Genoa, ItalyCa...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745283</comments>
            <pubDate>Tue, 19 Apr 2011 07:15:56 +0100</pubDate>
            <guid isPermaLink="false">4745283</guid>        </item>
        <item>
            <title>Necrotizing infundibulo-hypophysitis: an entity too rare to be true?</title>
            <link>http://www.medworm.com/index.php?rid=4710633&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw48m84v778v76t7m%2F</link>
            <description>We report a young woman with sudden and severe retroorbital headache, neck pain, and a large sellar mass extending to the
 suprasellar cistern. A presumptive diagnosis of non-secreting pituitary macroadenoma undergoing apoplexy was made and transphenoidal
 surgery performed. Histopathology revealed mononuclear infiltration and marked non-hemorrhagic necrosis of the anterior pituitary
 consistent with a diagnosis of necrotizing infundibulo-hypophysitis. The possible pathogenesis of this rare variant of hypophysitis
 is discussed.
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s11102-011-0307-2Authors
		Angelika Gutenberg, Department of Neurosurgery, University Medical Center, Georg August University, 37099 Göttingen, GermanyPatrizio Caturegli, Department of Pathology and Immunology,...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710633</comments>
            <pubDate>Sat, 09 Apr 2011 15:48:15 +0100</pubDate>
            <guid isPermaLink="false">4710633</guid>        </item>
        <item>
            <title>Excess mortality for patients with residual disease following resection of pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4698916&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw174n06277h34230%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The importance of achieving tumor control in pituitary adenoma surgery is not entirely established. This manuscript reviews
 the literature linking residual pituitary tumor and hormonal hypersecretion to increases in long term mortality. When possible,
 we utilized meta-analysis methods to estimate a pooled standardized mortality ratio (SMR), which relates the risk of mortality
 for a cohort of patients compared to a similar age and gender matched cohort in the general population, for patients with
 endocrinologic evidence of residual disease. When this was not possible, we review the existing literature in the results
 and discussion section of this review. We identified 10 articles regarding acromegaly and three articles regarding Cushing’s
 disease which presented ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4698916</comments>
            <pubDate>Thu, 07 Apr 2011 17:08:14 +0100</pubDate>
            <guid isPermaLink="false">4698916</guid>        </item>
        <item>
            <title>Spontaneous recovery of bone mass after cure of endogenous hypercortisolism</title>
            <link>http://www.medworm.com/index.php?rid=4698917&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdm03m724843713p4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients with Cushing’s syndrome (CS) develop osteopenia-osteoporosis. The present study evaluates the recovery of bone mass
 within 2&amp;nbsp;years after remission of hypercortisolism and in long term follow up, an issue rarely addressed. Twenty patients
 (6M, 14F, 3 post-menopausal, 15–64&amp;nbsp;years old), 15 with Cushing’s disease, 2 with ectopic ACTH syndrome, 3 with ACTH-independent
 CS were studied. BMD, T and Z scores at lumbar spine and proximal femur were assessed by dual-energy X-ray absorptiometry
 before and 7–33&amp;nbsp;months after treatment of hypercortisolism. Five patients were treated with bisphosphonates. Four patients
 had hypogonadism and 4 GH-deficiency. At baseline all patients showed osteopenia/osteoporosis and the spine appeared more
 damaged t...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4698917</comments>
            <pubDate>Thu, 07 Apr 2011 17:08:13 +0100</pubDate>
            <guid isPermaLink="false">4698917</guid>        </item>
        <item>
            <title>Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?</title>
            <link>http://www.medworm.com/index.php?rid=4671983&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2pv384412087822%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients with acromegaly have higher prevalence of colorectal neoplasms. The pathogenetic mechanism is still unclear and may
 be related to sustained increase in serum GH-IGF1. We aimed to evaluate the proliferative and apoptotic markers in samples
 of colonic mucosa obtained during screening colonoscopic biopsy from patients with acromegaly and study their relationship
 to serum IGF-1 and GH levels. The study subjects included 32 patients with acromegaly (4 female), 10 healthy controls (irritable
 bowel syndrome) and 10 positive controls (non-acromegalic colonic adenocarcinoma). Patients with acromegaly were divided into
 two groups, active disease (AD) and disease in remission (AR). Two biopsies each were obtained during colonoscopy from the
 right colon, transverse c...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4671983</comments>
            <pubDate>Wed, 30 Mar 2011 23:52:14 +0100</pubDate>
            <guid isPermaLink="false">4671983</guid>        </item>
        <item>
            <title>Sphenoid sinus pyocele after transsphenoidal approach for pituitary adenoma</title>
            <link>http://www.medworm.com/index.php?rid=4645046&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4jw8120x795316p2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Transsphenoidal pituitary adenoma surgery is related to a low morbidity rate. The complications that can occur are classified
 as intra- and extracranial. The aim of the study is to discuss one group of these complications involving the sphenoid sinus:
 mucocele and its possible transformation into pyocele. We evaluate clinical presentation, management strategy and the outcome
 after long-term follow-up presenting an explicative case and a review of the literature. A patient presented to our outpatient
 clinic 8&amp;nbsp;months after transsphenoidal surgery for selective removal of a pituitary adenoma because of an acute onset of frontal
 headache during an airplane travel, fever and pulsating sensation in left eye and ear. MRI revealed a contrast-enhancing lesion
 in the l...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645046</comments>
            <pubDate>Fri, 25 Mar 2011 18:50:46 +0100</pubDate>
            <guid isPermaLink="false">4645046</guid>        </item>
        <item>
            <title>Hematological response of pancytopenia to glucocorticoids in patients with Sheehan’s syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4632578&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp20656346468kn58%2F</link>
            <description>We present the clinical, hormonal, hematological course and response to glucocorticoids in a patient of Sheehan’s syndrome
 presenting with pancytopenia. Complete recovery of pancytopenia was observed after achieving eucortisolemic state thus concluding
 that gulcocorticoid replacement is sufficient to reverse pancytopenia in these patients.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s11102-011-0304-5Authors
		Bashir Ahmad Laway, Department of Endocrinology, Sher-I- Kashmir Institute of Medical Sciences Soura, Srinagar, Jammu and Kashmir IndiaShahnaz Ahmad Mir, Department of Endocrinology, Sher-I- Kashmir Institute of Medical Sciences Soura, Srinagar, Jammu and Kashmir IndiaJavid Rasool Bhat, Department of Clinical Hematology, Sher-I- Kashmir Institute of Medical Sciences Sour...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632578</comments>
            <pubDate>Mon, 21 Mar 2011 19:00:51 +0100</pubDate>
            <guid isPermaLink="false">4632578</guid>        </item>
        <item>
            <title>Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience</title>
            <link>http://www.medworm.com/index.php?rid=4611668&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc3673331133m2671%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dopamine agonists (DA) are the mainstay of treatment for patients with prolactinomas. To describe the efficacy of treatment
 and the outcomes of DA withdrawal. Retrospective review of electronic medical records of patients with prolactinomas from
 1985 to 2009. Seventy-nine patients (17 men/62 women), aged 35.3&amp;nbsp;±&amp;nbsp;1.6&amp;nbsp;years at diagnosis were studied. The mean follow-up
 time was 84.7&amp;nbsp;±&amp;nbsp;9.2&amp;nbsp;months (range 0–336). The mean initial size of microadenomas was 0.74&amp;nbsp;±&amp;nbsp;0.10&amp;nbsp;cm (range 2.41&amp;nbsp;±&amp;nbsp;0.39) and
 of macrodenomas 2.41&amp;nbsp;±&amp;nbsp;0.39&amp;nbsp;cm (range 1.1–8) and serum prolactin (PRL) levels were 112&amp;nbsp;±&amp;nbsp;19 and 263&amp;nbsp;±&amp;nbsp;59&amp;nbsp;ng/ml, respectively
 (normal range 0–40). Fifty-one (65%) prolactinoma...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611668</comments>
            <pubDate>Wed, 16 Mar 2011 12:00:07 +0100</pubDate>
            <guid isPermaLink="false">4611668</guid>        </item>
        <item>
            <title>“Glandular intoxication” following emergent tracheotomy during transsphenoidal surgery for acromegaly: Cushing’s 1910 unrecognized case of thyroid storm?</title>
            <link>http://www.medworm.com/index.php?rid=4578627&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa43353331g126800%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Harvey Cushing’s monograph The Pituitary Body and Its Disorders describes Case XXXVIII, H. M. B., a 33&amp;nbsp;year-old man who presented with acromegaly in 1910. The detailed operative note reports
 an emergency tracheotomy performed following induction of anesthesia, and immediately prior to a naso-labial approach to a
 suspected sellar lesion. Cushing’s post-operative notes document a significant increase in temperature prior to the patient’s
 death. Cushing offered an explanation for the patient’s symptoms immediately pre-mortem, which is largely unsatisfying. Following
 institutional review board approval, and through the courtesy of the Alan Mason Chesney Archives, the surgical records from
 the Johns Hopkins Hospital, 1896–1912, were reviewed. A review of ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578627</comments>
            <pubDate>Thu, 10 Mar 2011 17:13:27 +0100</pubDate>
            <guid isPermaLink="false">4578627</guid>        </item>
        <item>
            <title>Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units</title>
            <link>http://www.medworm.com/index.php?rid=4567254&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk2691222r6l23434%2F</link>
            <description>The objective of this study was to screen for acromegaly by application of a simple questionnaire in patients seen at primary
 health care units. A total of 17,000 patients of both genders &amp;gt;18 and &amp;lt;70&amp;nbsp;years seen by general practitioner were interviewed. Patients with known pituitary disease and pregnant women were excluded. A simple questionnaire was applied
 to the patients: Has your shoe size increased over the last 5&amp;nbsp;years? Did you have to change your wedding ring or ring over
 the last 5&amp;nbsp;years because it became tight? In one patient, the diagnosis of acromegaly was suspected by the physician. Among
 the remaining patients, 178 (1%) responded positively to one of the items of the questionnaire and were submitted to IGF-1
 measurement. Five patients had persistently ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4567254</comments>
            <pubDate>Mon, 07 Mar 2011 06:35:52 +0100</pubDate>
            <guid isPermaLink="false">4567254</guid>        </item>
        <item>
            <title>Short-duration, single-agent antibiotic prophylaxis for meningitis in trans-sphenoidal surgery</title>
            <link>http://www.medworm.com/index.php?rid=4541630&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft732456j03508jx3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Perioperative bacterial meningitis after trans-sphenoidal surgery for pituitary and parasellar lesions is an uncommon but
 serious complication. Little evidence guides the choice of chemoprophylaxis in this setting. To begin to address this deficiency,
 we investigated the incidence of perioperative meningitis in 442 patients who underwent trans-sphenoidal surgery and received
 a short chemoprophylaxis regimen with a single agent and did not require lumbar drainage. In 2005 we instituted a standardized
 antibiotic prophylaxis protocol for trans-sphenoidal surgery that utilized intravenous cefuroxime, a second-generation cephalosporin
 with broad coverage and excellent spinal fluid penetration, administered 30&amp;nbsp;min before surgery and 8&amp;nbsp;h later. The primary
 endp...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541630</comments>
            <pubDate>Wed, 23 Feb 2011 23:35:18 +0100</pubDate>
            <guid isPermaLink="false">4541630</guid>        </item>
        <item>
            <title>Ghrelin immunoexpression in pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4513683&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd84w57623u124836%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ghrelin, an orexigenic hormone, is normally produced mainly in stomach. In addition, it has been demonstrated in gastric carcinoid
 tumors and less often in other neuroendocrine tumors. We investigated ghrelin expression by immunohistochemistry (streptavidin–biotin-peroxidase
 complex method) in the full spectrum of resected pituitary adenoma subtypes. Quantification of staining considered both the
 frequency of ghrelin-reactive tumor cells as well as their staining intensity. Cytoplasmic ghrelin immunopositivity was identified
 in several adenoma subtypes. Cellular staining varied considerably. In addition, the intensity of cell staining differed within
 the same tumor and between adenoma subtypes. The highest scores were noted in GH producing adenomas exposed to lon...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513683</comments>
            <pubDate>Mon, 21 Feb 2011 17:07:07 +0100</pubDate>
            <guid isPermaLink="false">4513683</guid>        </item>
        <item>
            <title>Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL</title>
            <link>http://www.medworm.com/index.php?rid=4503037&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F688575m10p727h74%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Restless legs syndrome (RLS), a neurological sensory-motor disorder characterized by a compelling urge to move the limbs during
 the night, is a sleep disturbance that impairs quality of life. Prevalence of RLS and consequences on quality of life were
 investigated in acromegalic patients. Fifty-six patients (20 men, 55.0&amp;nbsp;±&amp;nbsp;1.6&amp;nbsp;years), 22 with active acromegaly (group 1) and 34 with controlled disease (group 2), and 95 controls (35 men, 52.9&amp;nbsp;±&amp;nbsp;1.1&amp;nbsp;years) were evaluated by a structured sleep interview concerning insomnia, circadian
 sleep disorders and excessive diurnal sleepiness (EDS). The Epworth Sleepiness Scale (ESS) questionnaire was administered
 to those reporting EDS. Patients were investigated by RLS diagnostic interview and Inte...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503037</comments>
            <pubDate>Thu, 17 Feb 2011 08:00:55 +0100</pubDate>
            <guid isPermaLink="false">4503037</guid>        </item>
        <item>
            <title>MGMT immunoexpression in adamantinomatous craniopharyngiomas</title>
            <link>http://www.medworm.com/index.php?rid=4484723&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F50k203123674lv4p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;At present, no effective medical treatment exists for recurrent and aggressive craniopharyngiomas that are resistant to conventional
 therapies, including surgery and adjuvant radiotherapy. Temozolomide is an alkylating chemotherapeutic agent used routinely
 in the management of high grade gliomas. The response to temozolomide is suggested to be dependent on the tumoral expression
 of O-6 methylguanine DNA methyltransferase (MGMT). Evidence supports that low MGMT immunoexpression correlates with positive response
 to temozolomide. Therefore, we aimed to assess MGMT immunoexpression in adamantinomatous craniopharyngiomas, in an effort
 to predict the likelihood of response to temozolomide. The MGMT immunostaining was performed on 23 adamantinomatous craniofaryngiomas
 op...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4484723</comments>
            <pubDate>Fri, 11 Feb 2011 11:52:45 +0100</pubDate>
            <guid isPermaLink="false">4484723</guid>        </item>
        <item>
            <title>Objective assessment of thirst recovery in patients with adipsic diabetes insipidus</title>
            <link>http://www.medworm.com/index.php?rid=4461126&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F25u2q61g7x1v6488%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adipsic diabetes insipidus (ADI) is characterised by impaired thirst and defective AVP secretion. We have assessed the thirst
 response to graded osmotic stimulation using a visual analog scale (VAS) in patients with a history of ADI following surgery
 for a craniopharyngioma. The patients were thought to be regaining their thirst response but we wanted to confirm that this
 was the case objectively before relaxing their strict fluid balance regimen. Three patients with adipisa in the presence of
 hypernatremia following surgery for a craniopharyngioma are described. Their median age at surgery was 13&amp;nbsp;years (range 11–15&amp;nbsp;years).
 All patients had previously demonstrated no desire to drink despite a serum osmolality in excess of 300&amp;nbsp;mOsmol/kg. Fluid balan...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4461126</comments>
            <pubDate>Mon, 07 Feb 2011 23:04:00 +0100</pubDate>
            <guid isPermaLink="false">4461126</guid>        </item>
        <item>
            <title>High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4461127&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr11725217p473402%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hyperprolactinemia may cause bone loss but data on fractures are scanty. The aim of this study was to evaluate the prevalence
 of vertebral fractures in women with prolactin (PRL)-secreting adenoma. In this cross-sectional study, 78 women (median age
 45.5&amp;nbsp;years, range: 20–81) with PRL-secreting pituitary adenoma (66 with microadenoma and 12 with macroadenoma) and 156 control
 subjects, with normal PRL values and with comparable age to patients with hyperprolactinemia, were evaluated for vertebral
 fractures by a morphometric approach and for bone mineral density (BMD) by a dual-energy X-ray absorptiometry at lumbar spine.
 Vertebral fractures were shown in 25 patients with PRL-secreting adenoma (32.6%) and in 20 controls (12.8%, P&amp;nbsp;&amp;lt;&amp;nbsp;0.001). Fracture...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4461127</comments>
            <pubDate>Mon, 07 Feb 2011 23:03:59 +0100</pubDate>
            <guid isPermaLink="false">4461127</guid>        </item>
        <item>
            <title>The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4451601&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F20g84jr85483200m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rapid assessment of adrenal function is critical following transsphenoidal surgery (TSS) for Cushing’s disease (CD) in order
 to determine surgical efficacy. We hypothesize that there may be a role for ACTH measurement as a rapid indicator of adrenal
 function. Following surgery for CD, glucocorticoids were withheld and paired plasma ACTH and serum cortisol levels were measured
 every 6&amp;nbsp;h. Post-operative hypocortisolemia was defined as serum cortisol &amp;lt;2&amp;nbsp;mcg/dl or a serum cortisol &amp;lt;5&amp;nbsp;mcg/dl with the
 onset of symptoms of adrenal insufficiency within 72&amp;nbsp;h. We studied 12 subjects, all female, mean age 44.6&amp;nbsp;years (range 25–55),
 including 13 surgeries: nine subjects attained hypocortisolemia. Plasma ACTH levels decreased more in subjects w...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451601</comments>
            <pubDate>Sat, 05 Feb 2011 16:56:25 +0100</pubDate>
            <guid isPermaLink="false">4451601</guid>        </item>
        <item>
            <title>The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4429965&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd2513v196838022v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The IL-17 plays a crucial role in the invasion of tumors. However, the effects of IL-17 on the invasion of human pituitary
 adenomas are still unknown. The current study is designed to investigate the possible involvement of IL-17 in the invasion
 of adenomas. By collecting invasive and non-invasive pituitary adenomas, the mRNA and protein levels of IL-17, IL-17R and
 MMP-9 are investigated. The results obtained from IHC showed that the strong positive rate and the total positive rate of
 IL-17, IL-17R and MMP-9 expression cells in the non-invasive group were 17.1 and 51.43%, 14.3 and 54.3%, 17.1 and 57.1%, respectively.
 In contrast, the strong positive rate and the total positive rate of the invasive group were significantly higher than that
 of the non-invasive group...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429965</comments>
            <pubDate>Sat, 29 Jan 2011 17:20:07 +0100</pubDate>
            <guid isPermaLink="false">4429965</guid>        </item>
        <item>
            <title>Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans’ cell histiocytosis</title>
            <link>http://www.medworm.com/index.php?rid=4429966&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8132uv4222j80r4x%2F</link>
            <description>We present a 22-year old male patient previously treated with radiotherapy and surgery at the age of 7 for an undefined suprachiasmatic
 mass. Following treatment he gradually became morbidly obese and besides subsequent panhypopituitarism he achieved his target
 height probably due to obesity-induced severe hyperinsulinemia. At the age of 21 Langerhans’ cell histiocytosis was diagnosed
 at the right mandible and was surgically treated. One year later he developed a further painful osteolytic hip lesion and
 a single zoledronate infusion eliminated all symptoms. We highlight the importance of obtaining a histological diagnosis before
 initiating treatment, and the distinctive course of the disease in a patient who continued to growth besides GH deficiency.
 
 
	Content Type Journal Artic...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429966</comments>
            <pubDate>Fri, 28 Jan 2011 20:43:05 +0100</pubDate>
            <guid isPermaLink="false">4429966</guid>        </item>
        <item>
            <title>Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide</title>
            <link>http://www.medworm.com/index.php?rid=4327591&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7q221472jg387403%2F</link>
            <description>We present the case of a 51-year old female patient with acromegaly that was resistant to somatostatin analogs and dopamine
 agonists. The patient was diagnosed with breast cancer requiring treatment with the anti-estrogen tamoxifen. Prior to initiating
 the treatment with tamoxifen, the IGF-I level was very high at 415% of the upper limit of normal for the patient’s age and
 sex. During the tamoxifen treatment, the level of IGF-I dropped spectacularly down to normal levels. This observation highlights
 the effect of an anti-estrogen treatment in certain female patients with acromegaly.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s11102-010-0287-7Authors
		Jean-Christophe Maiza, Department of Endocrinology and Metabolic Diseases, CHU Larrey, 24 Chemin de Pourvouville, TSA 30030...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4327591</comments>
            <pubDate>Fri, 07 Jan 2011 14:51:18 +0100</pubDate>
            <guid isPermaLink="false">4327591</guid>        </item>
        <item>
            <title>Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=4327593&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw2j44k475305272q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cabergoline and bromocriptine are the most used drugs in the treatment of hyperprolactinemia, they are able to normalize the
 prolactin levels, restore gonadal function and promote tumor reduction in the majority of patients. We undertake a systematic
 review and meta-analysis of randomized controlled trials to compare cabergoline versus bromocriptine in the treatment of patients
 with idiopathic hyperprolactinemia and prolactinomas. The data sources were: Embase, Pubmed, Lilacs and Cochrane Central.
 The outcome measures were: normalization of prolactin secretion, restoration of gonadal function, reduction of tumoral volume,
 quality of life and adverse drug effects. Were identified 418 references and after screening by title and abstract, we obtained
 complete copies ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4327593</comments>
            <pubDate>Fri, 07 Jan 2011 14:51:16 +0100</pubDate>
            <guid isPermaLink="false">4327593</guid>        </item>
        <item>
            <title>Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients</title>
            <link>http://www.medworm.com/index.php?rid=4327592&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw7636124w68267ut%2F</link>
            <description>We present two cases of a 31 and 44&amp;nbsp;years
 old male with gigantism and acromegaly that were controlled subsequently by surgery, radiotherapy, SRIF analogs and daily
 PEG-V treatment. They were converted to combined treatment of monthly SSA and (twice) weekly PEG-V. High dose SSA treatment
 was added while the PEG-V dose was decreased during carful monitoring of the IGF-I. After switching from PEG-V monotherapy
 to SRIF analogs plus pegvisomant combination therapy IGF-I remained normal. However, the necessary PEG-V dose, to normalize
 IGF-I differed significantly between these two patients. One patient needed twice weekly 100&amp;nbsp;mg, the second needed 60&amp;nbsp;mg once
 weekly on top of their monthly lanreotide Autosolution injections of 120&amp;nbsp;mg. The weekly dose reduction was 80 and...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4327592</comments>
            <pubDate>Fri, 07 Jan 2011 14:51:16 +0100</pubDate>
            <guid isPermaLink="false">4327592</guid>        </item>
        <item>
            <title>AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells</title>
            <link>http://www.medworm.com/index.php?rid=4325150&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6572q6050482g76%2F</link>
            <description>In conclusion, our studies showed that
 AMPK has a role in regulating somatotroph function in normal rat pituitary and proliferation of pituitary adenomatous cells.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s11102-010-0288-6Authors
		Giovanni Tulipano, Department of Biomedical Sciences and Biotechnologies, Unit of Pharmacology, University of Brescia, Viale Europa 11, 25123 Brescia, ItalyMichela Giovannini, Department of Biomedical Sciences and Biotechnologies, Unit of Pharmacology, University of Brescia, Viale Europa 11, 25123 Brescia, ItalyMaurizio Spinello, Novartis Farma SpA, Origgio, ItalyValeria Sibilia, Department of Pharmacology and Chemotherapy, University of Milan, Milan, ItalyAndrea Giustina, Department of Medical and Surgical Sciences, Unit of Endocrinology, Univers...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4325150</comments>
            <pubDate>Thu, 06 Jan 2011 17:56:14 +0100</pubDate>
            <guid isPermaLink="false">4325150</guid>        </item>
        <item>
            <title>Erratum to: Retrospective multicentric study of pituitary incidentalomas</title>
            <link>http://www.medworm.com/index.php?rid=4301085&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl166w615k868t57t%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11102-010-0279-7Authors
		Patricia Fainstein Day, Neuroendocrinology Department of the Argentine Society of Endocrinology and Metabolism, Buenos Aires (Departamento de Neuroendocrinolog´ıa de la Sociedad Argentina de Endocrinolog´ıa y Metabolismo, Buenos Aires), Díaz Velez, 3889, 1200 Buenos Aires, ArgentinaMirtha Guitelman, Neuroendocrinology Department of the Argentine Society of Endocrinology and Metabolism, Buenos Aires (Departamento de Neuroendocrinolog´ıa de la Sociedad Argentina de Endocrinolog´ıa y Metabolismo, Buenos Aires), Díaz Velez, 3889, 1200 Buenos Aires, ArgentinaRosa Artese, Neuroendocrinology Department of the Argentine Society of Endocrinology and Metabolism, Buenos Aires (Departamento de Neuroendocrinolog´ıa de la S...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301085</comments>
            <pubDate>Tue, 28 Dec 2010 15:37:58 +0100</pubDate>
            <guid isPermaLink="false">4301085</guid>        </item>
        <item>
            <title>Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=4301086&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc32n45p385503700%2F</link>
            <description>We present 2 cases of 1,25 (OH)2 D-dependent hypercalcemia associated with growth hormone excess. Complete resection of tumor produced biochemical remission
 of acromegaly and normalization of calcium and 1,25 (OH)2 D levels, while incomplete resection was associated with persistent 1,25 (OH)2 D-dependent hypercalcemia. Acromegaly should be considered a cause of 1,25 (OH)2 D-dependent hypercalcemia.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0286-8Authors
		Reshma Shah, Division of Endocrinology, Diabetes and Lipids. Department of Medicine, Emory University School of Medicine, 1365 B Clifton Rd NE, Atlanta, GA 30329, USAAngelo Licata, Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, OH 44195, USANelson M. Oyesiku, Division of Endocrinology, Di...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301086</comments>
            <pubDate>Tue, 28 Dec 2010 15:37:56 +0100</pubDate>
            <guid isPermaLink="false">4301086</guid>        </item>
        <item>
            <title>Intrapituitary cytokines in Cushing’s disease: do they play a role?</title>
            <link>http://www.medworm.com/index.php?rid=4289187&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm21882704206464x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A large body of in vitro evidence shows that cytokines influence the hypothalamic–pituitary–adrenal axis both in physiological
 conditions and in Cushing’s disease (CD). In order to study in vivo the role of intrapituitary cytokines in CD, we assayed
 two cytokines known for their action on the pituitary, i.e. interleukin-1 beta (IL-1β) and interleukin-6 (IL-6), and also
 soluble interleukin-6 receptor (sIL-6R), important for the neural activities of IL-6, in a carefully selected sample of subjects
 affected by CD undergoing bilateral inferior petrosal sinus sampling. Similarly to ACTH, all cytokines basally showed a higher
 concentration in the ipsilateral sinus compared to the controlateral one and to that of peripheral blood; after CRH infusion,
 both ipsilate...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4289187</comments>
            <pubDate>Wed, 22 Dec 2010 20:21:32 +0100</pubDate>
            <guid isPermaLink="false">4289187</guid>        </item>
        <item>
            <title>Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients</title>
            <link>http://www.medworm.com/index.php?rid=4289188&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F56w8617572673332%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The authors investigate the complications of transnasal transsphenoidal endoscopic surgery in the treatment of 301 patients
 with pituitary adenomas. A retrospective analysis of complications in 301 patients submitted to transsphenoidal transnasal
 endoscopic surgery at the General Hospital of Fortaleza, Brazil between January 1998 and December 2009. The complications
 were divided in two groups: anatomical (oronasofacial, sphenoid sinus, intrasellar, suprasellar and parasellar) and endocrinological
 complications (anterior and posterior pituitary dysfunctions). We observed a total of 81 complications (26.9%) in our series.
 Anatomical complications occurred in 8.97% (27 cases): 8 CSF postoperative leaks (2.6%), 6 cases (1.9%) of delayed nasal bleeding,
 5 cases (1.6%) ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4289188</comments>
            <pubDate>Wed, 22 Dec 2010 20:21:31 +0100</pubDate>
            <guid isPermaLink="false">4289188</guid>        </item>
        <item>
            <title>Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists</title>
            <link>http://www.medworm.com/index.php?rid=4273078&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F64r115h7317269um%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite the fact that consensus guidelines recommend long-term dopamine agonist (DA) therapy as a first-line approach to the
 treatment of small prolactinoma, some patients continue to prefer a primary surgical approach. Concerns over potential adverse
 effects of long-term medical therapy and/or the desire to become pregnant and avoid long-term medication are often mentioned
 as reasons to pursue surgical removal. In this retrospective study, 34 consecutive patients (30 female, 4 male) preferably
 underwent primary pituitary surgery without prior DA treatment for small prolactinomas (microprolactinoma 1–10&amp;nbsp;mm, macroprolactinoma
 11–20&amp;nbsp;mm) at the Department of Neurosurgery, University of Bern, Switzerland. At the time of diagnosis, 31 of 34 patients
 (91%)...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273078</comments>
            <pubDate>Fri, 17 Dec 2010 17:41:31 +0100</pubDate>
            <guid isPermaLink="false">4273078</guid>        </item>
        <item>
            <title>Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population</title>
            <link>http://www.medworm.com/index.php?rid=4273079&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm163g485115x0547%2F</link>
            <description>The objective of this study was to evaluate the frequency of acromegaly in adults with diabetes mellitus (DM) or glucose intolerance
 (GI) and to estimate its prevalence in the general population. A total of 2,270 patients with DM or GI and age from 20 to
 70&amp;nbsp;years were studied. Patients with known pituitary disease and pregnant women were excluded. Serum IGF-1 was measured in
 all subjects and, if elevated, a new measurement was obtained together with the measurement of GH in the oral glucose tolerance
 test (OGTT). Patients with persistently elevated IGF-1 and inadequate suppression of GH were submitted to magnetic resonance
 imaging (MRI). Acromegaly was not suspected by the assistant physician in any of the patients. Six patients had persistently
 elevated IGF-1 and inadequate sup...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273079</comments>
            <pubDate>Fri, 17 Dec 2010 17:41:29 +0100</pubDate>
            <guid isPermaLink="false">4273079</guid>        </item>
        <item>
            <title>Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism</title>
            <link>http://www.medworm.com/index.php?rid=4267859&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx3u6252595471524%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To determine the prevalence of diabetes, glucose intolerance and impaired fasting glucose in Mexican patients with acromegaly
 and establish associations with clinical, anthropometric and biochemical variables. 257 patients with acromegaly were evaluated
 by a 75&amp;nbsp;g-oral glucose tolerance test with measurements of both GH and glucose (0, 30, 60, 90 120&amp;nbsp;min) as well as baseline
 IGF-1. Normal glucose tolerance (NGT), impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and diabetes (DM)
 were defined based on the 2003 ADA criteria. NGT, IFG, IGT and DM were found in 27.6, 8.9, 31.6 and 31.9% of the subjects,
 respectively; 42 of the DM patients were unaware of the diagnosis. Patients with diabetes were older than subjects in the
 other 3 categories (...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267859</comments>
            <pubDate>Wed, 15 Dec 2010 16:01:34 +0100</pubDate>
            <guid isPermaLink="false">4267859</guid>        </item>
        <item>
            <title>Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review</title>
            <link>http://www.medworm.com/index.php?rid=4267860&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn622840053261603%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Acromegaly is a rare disease with a multifaceted clinical presentation. In 90–95% of patients with acromegaly, the disease
 is caused by a growth hormone (GH)-secreting pituitary adenoma with elevated GH levels that ultimately induce excessive hepatic
 secretion of insulin-like growth factor-1 (IGF-1). Somatostatin receptor ligands (SRLs) are considered the standard medical
 choice for the treatment of acromegaly, and normalization of GH and IGF-1 is attainable with effective therapy. This review
 aims to summarize the literature relative to SRL dose escalation therapy in patients with acromegaly. A United States National
 Library of Medicine PubMed search of SRL’s was conducted using the following search terms: ((((LAR) OR ATG) OR octreotide)
 OR lanreotide Autogel...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267860</comments>
            <pubDate>Wed, 15 Dec 2010 16:01:33 +0100</pubDate>
            <guid isPermaLink="false">4267860</guid>        </item>
        <item>
            <title>Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency</title>
            <link>http://www.medworm.com/index.php?rid=4242845&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy8l337175u43r437%2F</link>
            <description>This study
 suggests that currently known genetic causes are rare in sporadic adult IPI patients, and that systematic genetic screening
 is not needed in adult-onset sporadic cases of IPI. Conversely, familial cases are highly suspect for genetic causes.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0278-8Authors
		Helena Filipsson Nyström, Department of Endocrinology, Sahlgrenska Academy, University of Gothenburg, Gröna Stråket 8, 41345 Gothenburg, SwedenAlexandru Saveanu, Department of Endocrinology, Centre Hospitalo-Universitaire Timone, Marseille, FranceEdna J. L. Barbosa, Department of Endocrinology, Sahlgrenska Academy, University of Gothenburg, Gröna Stråket 8, 41345 Gothenburg, SwedenAnne Barlier, Department of Endocrinology, Centre Hospitalo-Universitaire Timone, Ma...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4242845</comments>
            <pubDate>Mon, 06 Dec 2010 15:08:38 +0100</pubDate>
            <guid isPermaLink="false">4242845</guid>        </item>
        <item>
            <title>Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy</title>
            <link>http://www.medworm.com/index.php?rid=4231123&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F129268854t58700r%2F</link>
            <description>In conclusion, beneficial metabolic changes were seen in prolactinoma patients after treatment with DA agonists,
 underscoring the importance of an active treatment approach and to consider the metabolic profile in the clinical management
 of hyperprolactinemia patients.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0277-9Authors
		Katarina Berinder, Department of Molecular Medicine and Surgery, Endocrine and Diabetes Unit, Karolinska Institutet, 171 76 Stockholm, SwedenThomas Nyström, Department of Internal Medicine, Karolinska Institutet and South Hospital, Stockholm, SwedenCharlotte Höybye, Department of Molecular Medicine and Surgery, Endocrine and Diabetes Unit, Karolinska Institutet, 171 76 Stockholm, SwedenKerstin Hall, Department of Molecular Medicine and Surgery, Endoc...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231123</comments>
            <pubDate>Thu, 02 Dec 2010 18:15:55 +0100</pubDate>
            <guid isPermaLink="false">4231123</guid>        </item>
        <item>
            <title>Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case report</title>
            <link>http://www.medworm.com/index.php?rid=4209028&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4663777031814t61%2F</link>
            <description>In this report, an extremely rare case of pediatric thyrotropin-secreting pituitary macroadenoma (TSHoma) is described. An
 8-year-old boy, complaining of unsteady gait, was suspected of endocrinopathy because of emaciation and muscle weakness of
 the legs. Endocrinological work-up established a diagnosis of hyperthyroidism due to syndrome of inappropriate secretion of
 TSH. Magnetic resonance imaging showed a pituitary macroadenoma with suprasellar and sphenoidal extension without cavernous
 sinus invasion. He underwent an endoscopic endonasal transsphenoidal adenomectory due to the diagnosis of TSHoma. The adenoma
 was soft and it was totally removed. Histopathological staining confirmed diagnosis of TSHoma. Postoperative evaluation revealed
 a subnormal level of TSH (from 13–21 to 0.0...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4209028</comments>
            <pubDate>Fri, 26 Nov 2010 18:08:40 +0100</pubDate>
            <guid isPermaLink="false">4209028</guid>        </item>
        <item>
            <title>Analysis of thrombophilic genetic mutations in patients with Sheehan`s syndrome: is thrombophilia responsible for the pathogenesis of Sheehan`s syndrome?</title>
            <link>http://www.medworm.com/index.php?rid=4206556&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5p03vjt5u6640h4q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The gene mutations of Factor V R506Q (FV-Leiden), prothrombin (FII G20210A), methylene tetrahydrofolate reductase (MTHFR)
 C677T and A1298C and PAI-1 4G/5G are well-established risk factors for thrombosis. We aimed to investigate the prevalence
 of these gene mutations and their possible impact on the development of pathogenesis in patients with Sheehan’s syndrome (SS).
 40 female patients with SS compared to a control group of 45 healthy women. The presence of FV-Leiden, FII G20210A, MTHFR
 C677T, MTHFR A1298C and PAI-1 4G/5G gene mutations were assessed by polymerase chain reaction analysis with a light cycler
 analyzer. An odds ratio of greater than one is considered to increase the risk of SS disease as found in Factor V Leiden,
 FII G20210A, MTHFR C677T, MTHFR A1...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4206556</comments>
            <pubDate>Wed, 24 Nov 2010 20:21:40 +0100</pubDate>
            <guid isPermaLink="false">4206556</guid>        </item>
        <item>
            <title>Efficacy and complications of neurosurgical treatment of acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=4206557&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F42u6082g7378n685%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the study was to evaluate the frequency of occurrence of pituitary failure following neurosurgery and the efficacy
 of transsphenoidal tumour resection in acromegalic patients. We retrospectively evaluated 85 patients (60 female and 25 male),
 of mean age 43.9&amp;nbsp;±&amp;nbsp;13.2&amp;nbsp;years, treated by transsphenoidal neurosurgery. Macroadenoma and microadenoma of pituitary were found
 in 66 (77.6%) and 19 (22.4%) of these patients, respectively. Criteria of cure following neurosurgery were: basal GH&amp;nbsp;&amp;lt;&amp;nbsp;2.5&amp;nbsp;μg/l,
 GH at 120&amp;nbsp;min in OGTT&amp;nbsp;&amp;lt;&amp;nbsp;1.0&amp;nbsp;μg/l and serum concentration of IGF-1 within normal ranges for age and sex. After surgery 32 patients
 (37.6%) were cured and 53 patients (62.4%) required somatostatin analogue trea...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4206557</comments>
            <pubDate>Wed, 24 Nov 2010 20:21:39 +0100</pubDate>
            <guid isPermaLink="false">4206557</guid>        </item>
        <item>
            <title>Transnasal trans-sphenoidal endoscopic repair of CSF leak secondary to invasive pituitary tumours using a nasoseptal flap</title>
            <link>http://www.medworm.com/index.php?rid=4203978&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq706827548811q3w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cerebrospinal fluid (CSF) leak following initiation of Dopamine agonist therapy for macroprolactinomas, although uncommon,
 has been described previously in the literature. Traditional management includes primary repair of the defect using either
 fat or fascia lata in conjunction with lumbar drain insertion. In this case series we outline two cases of CSF leak secondary
 to invasive pituitary tumour that were repaired successfully using a nasoseptal flap. We believe that this form of repair
 is effective and associated with minimal morbidity.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0274-zAuthors
		B. Thakur, Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Glossop Road, Sheffield, S10 2JF UKA. R. Jesurasa, ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4203978</comments>
            <pubDate>Tue, 23 Nov 2010 18:16:12 +0100</pubDate>
            <guid isPermaLink="false">4203978</guid>        </item>
        <item>
            <title>Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR</title>
            <link>http://www.medworm.com/index.php?rid=4192492&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp78915k18312q411%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this prospective open trial was to evaluate the efficacy in normalizing IGF-I levels of the addition of cabergoline
 to the treatment of acromegalic patients partially responsive to Octreotide-LAR (OCT-LAR), a long acting somatotastin analog
 (SSA). Fifty-two patients who did not achieve hormonal control after longterm therapy (at least, 12&amp;nbsp;months) with OCT-LAR (30&amp;nbsp;mg
 every 28&amp;nbsp;days intramuscularly) were given cabergoline in addition to the SSA treatment. Normalization of IGF-I levels was
 achieved in 40.4% of patients by 6&amp;nbsp;months after the addition of cabergoline (1.0–3.0&amp;nbsp;mg/week; mean, 2.19&amp;nbsp;±&amp;nbsp;0.64), and these
 patients were considered responsive. Compared to non-responsive subjects, responsive patients had significantly...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4192492</comments>
            <pubDate>Sat, 20 Nov 2010 17:52:31 +0100</pubDate>
            <guid isPermaLink="false">4192492</guid>        </item>
        <item>
            <title>In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5</title>
            <link>http://www.medworm.com/index.php?rid=4187430&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F776p524263u70156%2F</link>
            <description>In conclusion,
 the significant antisecretive and antiproliferative effect of octreotide in this patient might be related to the high expression
 of SSTR5, in the presence of SSTR2. After reviewing the literature, indeed, in line with previous observations, we hypothesize
 that SSTR5/SSTR2 ratio in TSHomas may represent a useful marker in predicting the outcome of therapy with SSAs. The role of
 D2R should be further explored considering that the presence of D2R can influence SSTRs functionality.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0271-2Authors
		Federico Gatto, Department of Endocrine and Medical Sciences (DiSEM) &amp; Center of Excellence for Biomedical Research, University of Genova, Viale Benedetto XV, 6, 16132 Genova, ItalyFederica Barbieri, Laboratory of Pharmacology...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4187430</comments>
            <pubDate>Wed, 17 Nov 2010 21:07:43 +0100</pubDate>
            <guid isPermaLink="false">4187430</guid>        </item>
        <item>
            <title>Current management practices for acromegaly: an international survey</title>
            <link>http://www.medworm.com/index.php?rid=4160434&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv7086w77652364m1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To determine whether peer-reviewed consensus statements have changed clinical practice, we surveyed acromegaly care in specialist
 centers across the globe, and determined the degree of adherence to published consensus guidelines on acromegaly management.
 Sixty-five acromegaly experts who participated in the 7th Acromegaly Consensus Workshop in March 2009 responded. Results indicated
 that the most common referring sources for acromegaly patients were other endocrinologists (in 26% of centers), neurosurgeons
 (25%) and primary care physicians (21%). In sixty-nine percent of patients, biochemical diagnoses were made by evaluating
 results of a combination of growth hormone (GH) nadir/basal GH and elevated insulin like growth factor-I (IGF-I) levels. In
 both Europe and ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4160434</comments>
            <pubDate>Wed, 10 Nov 2010 10:54:21 +0100</pubDate>
            <guid isPermaLink="false">4160434</guid>        </item>
        <item>
            <title>MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=4156244&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7r2r6wg575313x48%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAs (miRs) are small, 16–29 nucleotide long, non-coding RNA molecules which regulate the stability or translational
 efficiency of targeted mRNAs via RNA interference. MiRs participate in the control of cell proliferation, cell differentiation,
 signal transduction, cell death, and they play a role in carcinogenesis. The aims of our study were to analyse the expression
 profile of miRs in sporadic clinically non-functioning pituitary adenomas (NFPA) and in normal pituitary tissues, and to identify
 biological pathways altered in these pituitary tumors. MiR expression profiles of 12 pituitary tissue specimens (8 NFPA and
 4 normal pituitary tissues) were determined using miR array based on quantitative real-time PCR with 678 different primers.
 Five overexpressed...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4156244</comments>
            <pubDate>Tue, 09 Nov 2010 12:52:24 +0100</pubDate>
            <guid isPermaLink="false">4156244</guid>        </item>
        <item>
            <title>The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults</title>
            <link>http://www.medworm.com/index.php?rid=4152982&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F135321p5272g4385%2F</link>
            <description>This study was performed to compare 1&amp;nbsp;μg ACTH, 250&amp;nbsp;μg ACTH and glucagon
 tests in the evaluation of HPA axis. The study was carried out on 55 healthy individuals (28 men, 27 women). 10–12 volunteers
 were included from every decades between 20 and 70&amp;nbsp;years. Low dose short synacthen test (1&amp;nbsp;μg ACTH), standard dose short synacthen
 test (250&amp;nbsp;μg ACTH) and glucagon tests were performed consecutively. The mean peak cortisol response to standard dose ACTH
 stimulation test was found to be significantly higher than the low dose ACTH and glucagon stimulation tests. The mean peak
 cortisol responses to low dose ACTH and the glucagon stimulation tests were not significantly different. The mean peak cortisol
 responses did not differ significantly between different age ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4152982</comments>
            <pubDate>Mon, 08 Nov 2010 19:19:19 +0100</pubDate>
            <guid isPermaLink="false">4152982</guid>        </item>
        <item>
            <title>Carotid atheromatic plaque is commonly associated with hypopituitary men</title>
            <link>http://www.medworm.com/index.php?rid=4120619&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh5x11k5212240996%2F</link>
            <description>In conclusion, hypopituitary males exhibit an increased incidence of carotid artery plaque without differences
 of carotid IMTs, central obesity and higher total cholesterol level. Lower testosterone levels were associated with central
 obesity- a strong component of a metabolic syndrome, and unsubstituted testosterone deficiency might be an important cardiovascular
 risk factor in patients with hypopituitarism.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0265-0Authors
		Joo Young Kim, Endocrinology, Internal Medicine, Institute of Endocrine Research, Yonsei University College of Medicine, 250 Seongsanno Seodaemun-Gu, 120-752 Seoul, KoreaJae Won Hong, Endocrinology, Internal Medicine, Institute of Endocrine Research, Yonsei University College of Medicine, 250 Seongsanno Seodaem...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4120619</comments>
            <pubDate>Wed, 27 Oct 2010 16:14:42 +0100</pubDate>
            <guid isPermaLink="false">4120619</guid>        </item>
        <item>
            <title>Temozolomide for corticotroph pituitary adenomas refractory to standard therapy</title>
            <link>http://www.medworm.com/index.php?rid=4110550&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx91374r24773t634%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To highlight the potential of temozolomide (TMZ) to induce rapid tumor regression in patients with aggressive corticotroph
 adenomas (CA) that are refractory to surgery and radiation therapy and to review use of TMZ in other pituitary tumors. We
 present a case of a 56-year-old male with a 3&amp;nbsp;cm CA treated with transphenoidal surgery (TSS) and conventional radiotherapy
 in the same year. His hypercortisolemia recurred 11&amp;nbsp;years later with rapid tumor growth (to 4.2&amp;nbsp;×&amp;nbsp;2.5&amp;nbsp;cm) and he underwent
 a second TSS with good resection. The tumor recurred 6&amp;nbsp;months later with ophthalmoplegia. Over 16&amp;nbsp;months he underwent an additional
 three surgeries (two TSS, one craniotomy) and repeated conventional radiotherapy. Ki67 staining index on surgical s...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4110550</comments>
            <pubDate>Sat, 23 Oct 2010 15:48:19 +0100</pubDate>
            <guid isPermaLink="false">4110550</guid>        </item>
        <item>
            <title>Is left ventricular dysfunction reversed after treatment of active acromegaly?</title>
            <link>http://www.medworm.com/index.php?rid=4090188&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F957224517l115733%2F</link>
            <description>In conclusion, the results of the present study indicate an improvement of left ventricular diastolic function
 and a significant improvement of cardiac hypertrophy in patients with inactive acromegaly and normal systolic cardiac function
 compared to those with active disease.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0263-2Authors
		Savvas T. H. Toumanidis, Department of Clinical Therapeutics, Medical School, University of Athens, “Alexandra” Hospital, 80 Vas. Sophias Ave.—Lourou Str., 115 28 Athens, GreeceMaria Eleftheria Evangelopoulos, Department of Clinical Therapeutics, Medical School, University of Athens, “Alexandra” Hospital, 80 Vas. Sophias Ave.—Lourou Str., 115 28 Athens, GreeceIoannis Ilias, Department of Clinical Therapeutics, Medical School, Univers...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4090188</comments>
            <pubDate>Wed, 20 Oct 2010 18:00:13 +0100</pubDate>
            <guid isPermaLink="false">4090188</guid>        </item>
        <item>
            <title>Pituicytoma in a patient with Cushing’s disease: case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=4069015&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh22022134827275l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pituicytoma is an exceptionally rare low-grade glioma (WHO grade I) of the neurohypophysis and infundibulum. We are reporting
 the case of a 48-year-old man who presented with severe Cushing′s syndrome. Endocrinological evaluation unequivocally confirmed
 pituitary-dependent Cushing’s syndrome (=Cushing’s disease). Cranial MR-imaging displayed a conspicuous area in the dorsal
 and basal pituitary gland and a minimal bulging of the pituitary gland paramedian of the pituitary stalk on the right side.
 Transsphenoidal inspection revealed a small tumor in the basal and dorsal pituitary gland. Surprisingly, the definite postoperative
 histopathological diagnosis of the removed tumor was pituicytoma and not pituitary adenoma. Hence, the microadenoma responsible
 for Cus...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4069015</comments>
            <pubDate>Thu, 14 Oct 2010 06:15:13 +0100</pubDate>
            <guid isPermaLink="false">4069015</guid>        </item>
        <item>
            <title>Children with Cushing’s syndrome: primary pigmented nodular adrenocortical disease should always be suspected</title>
            <link>http://www.medworm.com/index.php?rid=4041857&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3095564q1tlv5508%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Primary Pigmented Nodular Adrenocortical Disease (PPNAD) is a rare form of bilateral adrenocortical hyperplasia that is inherited
 in an autosomal dominant manner and leads to ACTH-independent Cushing’s syndrome (CS). PPNAD may be isolated or associated
 with Carney Complex (CNC). For the diagnosis of PPNAD and CNC, in addition to the hormonal and imaging tests, searching for
 PRKAR1A mutations may be recommended. The aims of the present study are to discuss the clinical and molecular findings of two Brazilian
 patients with ACTH-independent CS due to PPNAD and to show the diagnostic challenge CS represents in childhood. Description
 of two patients with CS and the many sequential steps for the diagnosis of PPNAD is provided. Sequencing analysis of all coding
 exons o...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4041857</comments>
            <pubDate>Tue, 05 Oct 2010 18:08:25 +0100</pubDate>
            <guid isPermaLink="false">4041857</guid>        </item>
        <item>
            <title>Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia</title>
            <link>http://www.medworm.com/index.php?rid=4037817&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdk7hnp70753g5w02%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mammary hyperplasia increases breast cancer risk. Tamoxifen prevents breast cancer in women with atypical hyperplasia, but
 has serious side effects. As estradiol action requires IGF-I, direct inhibition of IGF-I action theoretically might be an
 efficacious alternative to tamoxifen. After hypophysectomy and oophorectomy, 21-day-old female rats were treated with GH and
 E2. After 7&amp;nbsp;days all terminal end buds (TEBs) and 75% of ducts became hyperplastic. Co-treatment with pasireotide, a somatostatin
 analog that blocks GH secretion and IGF-I action in the mammary gland, prevented hormone-induced hyperplasia. The number and
 size of TEBs and moderately or floridly hyperplastic ducts was reduced by pasireotide (P&amp;nbsp;&amp;lt;&amp;nbsp;0.01). In contrast, the same concentratio...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4037817</comments>
            <pubDate>Sat, 02 Oct 2010 05:55:26 +0100</pubDate>
            <guid isPermaLink="false">4037817</guid>        </item>
        <item>
            <title>Effect of dopaminergic drug treatment on surgical findings in prolactinomas</title>
            <link>http://www.medworm.com/index.php?rid=4005699&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx885168x23x04784%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been reported that prolactinomas treated with Bromocriptine (BROM) show fibrosis that may interfere with complete surgical
 resection. The same has not been reported for Cabergoline (CAB). We retrospectively studied 24 consecutive patients (13 females,
 mean age 40&amp;nbsp;years, range 16–60) with histopathologically confirmed prolactinomas undergoing surgical resection at Johns Hopkins
 Hospital between 1992 and 2009. We compared these prolactinomas to 34 patients (22 females, mean age 42.9&amp;nbsp;years, range 15–75)
 with GH-secreting adenoma. The operative notes from 7 different neurosurgeons were reviewed to catalog the tumors as fibrous
 or not fibrous. Of the 24 prolactinomas, 21 (87.5%) were previously treated with DA. Indication for surgery was: DA resista...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4005699</comments>
            <pubDate>Mon, 27 Sep 2010 16:51:51 +0100</pubDate>
            <guid isPermaLink="false">4005699</guid>        </item>
        <item>
            <title>Unmasking of undiagnosed pre-existing central diabetes insipidus after renal transplantation</title>
            <link>http://www.medworm.com/index.php?rid=3948240&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdn5hp356x53425l5%2F</link>
            <description>We present a case of a patient with pre-existing and clinically unapparent CDI which was unmasked after renal transplantation.
 A 60&amp;nbsp;year old woman with end-stage renal failure due to autosomal dominant polycystic kidney disease (ADPKD) underwent renal
 transplantation. She was noted to be markedly polyuric and polydipsic after the transplant. A fluid deprivation test was unequivocally
 positive for CDI, and desmopressin treatment resulted in immediate symptom relief. Neuroimaging revealed a midline defect
 in the region of the hypothalamus. She had a history of an intracerebral aneurysm that had ruptured, requiring extensive neurosurgery
 many years previously. This case demonstrates a rare instance of pre-existing but clinically unapparent CDI unmasked by renal
 transplantation. It ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948240</comments>
            <pubDate>Wed, 08 Sep 2010 05:26:52 +0100</pubDate>
            <guid isPermaLink="false">3948240</guid>        </item>
        <item>
            <title>On the shoulders of giants: Harvey Cushing’s experience with acromegaly and gigantism at the Johns Hopkins Hospital, 1896–1912</title>
            <link>http://www.medworm.com/index.php?rid=3948239&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm517g5t382k63410%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A review of Dr. Cushing’s surgical cases at Johns Hopkins Hospital revealed new information about his early operative experience
 with acromegaly. Although in 1912 Cushing published selective case studies regarding this work, a review of all his operations
 for acromegaly during his early years has never been reported. We uncovered 37 patients who Cushing treated with surgical
 intervention directed at the pituitary gland. Of these, nine patients who presented with symptoms of acromegaly, and one with
 symptoms of gigantism were selected for further review. Two patients underwent transfrontal ‘omega incision’ approaches, and
 the remaining eight underwent transsphenoidal approaches. Of the 10 patients, 6 were male. The mean age was 38.0&amp;nbsp;years. The
 mean hospi...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948239</comments>
            <pubDate>Wed, 08 Sep 2010 05:26:52 +0100</pubDate>
            <guid isPermaLink="false">3948239</guid>        </item>
        <item>
            <title>Comparison of three methods for the estimation of the pituitary gland volume using magnetic resonance imaging: a stereological study</title>
            <link>http://www.medworm.com/index.php?rid=3930539&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm64g74183k31h8u7%2F</link>
            <description>In this study, pituitary gland volumes were estimated in a total of 28 subjects (22 females, 6 males,) who were free
 of any pituitary or neurological symptoms and signs. The mean&amp;nbsp;±&amp;nbsp;SD pituitary gland volumes for the point counting, planimetry
 and elliptic formulae groups were 582.14&amp;nbsp;±&amp;nbsp;140.16&amp;nbsp;mm3, 610.08&amp;nbsp;±&amp;nbsp;133.17&amp;nbsp;mm3, and 432.82&amp;nbsp;±&amp;nbsp;147.38&amp;nbsp;mm3, respectively. The mean CE for the pituitary gland volume estimates derived from the point counting technique was 8.07%.
 No significant difference was found between point counting and planimetric methods for the pituitary gland volume (P&amp;nbsp;&amp;gt;&amp;nbsp;0.05). In addition, there was a 26.14 and 29.71% underestimation of pituitary volume as measured by the elliptic formula
 compared to the poin...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3930539</comments>
            <pubDate>Thu, 02 Sep 2010 08:40:19 +0100</pubDate>
            <guid isPermaLink="false">3930539</guid>        </item>
        <item>
            <title>Azathioprine as an alternative treatment in primary hypophysitis</title>
            <link>http://www.medworm.com/index.php?rid=3930540&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv458n482112p1744%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Primary hypophysitis (PH) is an unusual disorder characterized by inflammatory infiltration of the pituitary gland with various
 degree of pituitary dysfunction. Glucocorticoids are the treatment of choice in the majority of patients. Still, in patients
 with poor response in glucocorticoids or when their administration is accompanied with serious side effects, the use of alternative
 agents should be considered; up to now, data on other therapeutic approaches remains scant mainly due to the rarity of the
 disease. Among them, the immunosuppressant azathioprine could represent an effective and safe alternative. In this article,
 we present our clinical experience of two cases with PH successfully treated with azathioprine following serious side effects
 after initial tr...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3930540</comments>
            <pubDate>Thu, 02 Sep 2010 08:40:17 +0100</pubDate>
            <guid isPermaLink="false">3930540</guid>        </item>
        <item>
            <title>Prophylactic antibiotic trends in transsphenoidal surgery for pituitary lesions</title>
            <link>http://www.medworm.com/index.php?rid=3930541&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl23703575r10n42w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pituitary surgery involves operating in the nasal cavity, which is considered a clean-contaminated wound. In the absence of
 evidence-based guidelines for preventing surgical site infections in trans-sphenoidal surgery, a survey of current opinion
 on prophylactic antibiotics might help elucidate the current acceptable practices and identify opportunities for prospective
 clinical trials that could lead to the development of practice guidelines. An on-line, 10-question, multiple-choice survey
 was distributed by e-mail link to the membership of the International Society of Pituitary Surgeons. Sixty-nine members responded
 to the survey. Ninety-one percent indicated that there was no strong evidence supporting antibiotic use, but 81% used them
 to be safe. Ninety percent...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3930541</comments>
            <pubDate>Thu, 02 Sep 2010 08:40:16 +0100</pubDate>
            <guid isPermaLink="false">3930541</guid>        </item>
        <item>
            <title>Demographic differences in incidence for pituitary adenoma</title>
            <link>http://www.medworm.com/index.php?rid=3930542&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4827v21021t804pw%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Incidence estimates for pituitary adenomas vary widely, suggesting the effects of numerous risk factors or varying levels
 of tumor surveillance. We studied the epidemiology of pituitary adenomas using 2004–2007 data collected by 17 Surveillance,
 Epidemiology, and End Results Programs in the United States (N&amp;nbsp;=&amp;nbsp;8,276). We observed that incidence rates generally increased with age and were higher in females in early life and higher
 in males in later life. Males are diagnosed with larger tumors on average than females. Diagnosis may be delayed for males,
 giving tumors a chance to grow larger before clinical detection. We also observed that American Blacks have higher incidence
 rates for pituitary adenomas compared with other ethnic groups. There are several...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3930542</comments>
            <pubDate>Thu, 02 Sep 2010 08:40:15 +0100</pubDate>
            <guid isPermaLink="false">3930542</guid>        </item>
        <item>
            <title>Prevalence of hematological abnormalities in patients with Sheehan’s syndrome: response to replacement of glucocorticoids and thyroxine</title>
            <link>http://www.medworm.com/index.php?rid=3912404&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh4316666lr7r2051%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Anemia and other hematological abnormalities are common in patients with Sheehan’s syndrome. The response of these abnormalities
 to replacement of thyroxine and glucocorticoids is not clear. The aim of the present study was to document the profile of
 hematological abnormalities and response to treatment in patients with Sheehan’s syndrome. Forty patients of Sheehan’s syndrome
 and an equal number of age and parity matched healthy controls were studied for prevalence of hematological abnormalities.
 Hemoglobin concentration, hematocrit, red cell, white cell and platelet count were significantly decreased in patients with
 Sheehan’s syndrome compared to controls. Frequency of anemia, leucopenia, thrombocytopenia and pancytopenia was significantly
 higher in thes...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3912404</comments>
            <pubDate>Thu, 26 Aug 2010 18:16:33 +0100</pubDate>
            <guid isPermaLink="false">3912404</guid>        </item>
        <item>
            <title>MGMT immunoexpression in aggressive pituitary adenoma and carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3912405&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4u132401180x4341%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent case reports have documented the efficacy of temozolomide therapy in some aggressive pituitary adenomas and pituitary
 carcinomas resistant to multimodality therapy. Evidence suggests that low O6-methylguanine-DNA methyltransferase (MGMT) immunoexpression
 correlates with response to temozolomide chemotherapy. Herein, we aimed to study MGMT immunoexpression in a spectrum of pituitary
 tumors, indolent, aggressive and malignant. A literature review of the use of temozolomide in pituitary tumors was also performed.
 Immunohistochemistry for MGMT was performed on 60 pituitary tumors identified in the Mayo Clinic Tissue Registry and the consultation
 files of one of us (BWS). The group included 30 pituitary carcinomas (15 ACTH, 10 PRL, 1 FSH/LH, 1 TSH, 1 silent subty...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3912405</comments>
            <pubDate>Thu, 26 Aug 2010 08:16:11 +0100</pubDate>
            <guid isPermaLink="false">3912405</guid>        </item>
        <item>
            <title>Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study</title>
            <link>http://www.medworm.com/index.php?rid=3889819&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgknx2223643t3176%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Assessed by conventional echocardiography the influence of growth hormone deficiency (GHD) and effects of replacement therapy
 on left ventricle (LV) function and mass (LVM) have shown inconsistent results. We aimed to evaluate cardiac function before
 and during replacement therapy employing the gold standard method cardiac magnetic resonance imaging (CMRI) and measurements
 of circulating levels of B-type natriuretic peptides. Sixteen patients (8 males and 8 females, mean age 49&amp;nbsp;years (range 18–75))
 with severe GHD and 16 matched control subjects were included. CMRI was performed at baseline and after 1&amp;nbsp;year of GH replacement
 therapy. IGF-I, B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) were measured after 0, 1, 2, 3, 6 and
 12&amp;nbsp...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3889819</comments>
            <pubDate>Fri, 20 Aug 2010 17:03:29 +0100</pubDate>
            <guid isPermaLink="false">3889819</guid>        </item>
        <item>
            <title>Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression</title>
            <link>http://www.medworm.com/index.php?rid=3878450&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F02x3kpl26t6q3070%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Men with hypogonadism tend to have low hemoglobin (HGB) levels. We have investigated a cohort of 36 consecutive male patients
 with macroprolactinomas to evaluate HGB during presentation and following treatment with cabergoline to suppress prolactin
 (PRL). Patients’ mean age at diagnosis was 48&amp;nbsp;years, the mean adenoma size measured 31&amp;nbsp;mm. The median PRL at baseline was
 1,969&amp;nbsp;ng/ml; the mean testosterone level was low, 1.5&amp;nbsp;ng/ml. PRL had been successfully normalized in all but six men by using
 cabergoline. Mean baseline HGB at diagnosis was 13.1&amp;nbsp;gr%. Sixteen patients had HGB ≤&amp;nbsp;13&amp;nbsp;gr%, including 4 men with HGB ≤&amp;nbsp;11.5&amp;nbsp;gr%.
 In the subgroup of 15 men with very low testosterone (≤1&amp;nbsp;ng/ml), baseline HGB was 12.6&amp;nbs...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3878450</comments>
            <pubDate>Tue, 17 Aug 2010 17:22:02 +0100</pubDate>
            <guid isPermaLink="false">3878450</guid>        </item>
        <item>
            <title>The elusive Minnie G.: revisiting Cushing’s case XLV, and his early attempts at improving quality of life</title>
            <link>http://www.medworm.com/index.php?rid=3874016&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft468n94tnp240617%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although researchers have discovered that Minnie G. had nearly 50&amp;nbsp;years of progression-free survival, the absence of her original
 surgical records have precluded anything more than speculation as to the etiology of her symptoms or the details of her admission.
 Following IRB approval, and through the courtesy of the Alan Mason Chesney Archives, the microfilm surgical records from the
 Johns Hopkins Hospital, 1896–1912 were reviewed. Using the surgical number provided in Cushing’s publications, the record
 for Minnie G. was recovered for further review. Cushing’s diagnosis relied largely on history and physical findings. Minnie
 G. presented with stigmata associated with classic Cushings Syndrome: abdominal stria, supraclavicular fat pads, and a rounded
 face...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3874016</comments>
            <pubDate>Sat, 14 Aug 2010 16:45:55 +0100</pubDate>
            <guid isPermaLink="false">3874016</guid>        </item>
        <item>
            <title>ACTH-producing remnants following apoplexy of an ACTH-secreting pituitary macroadenoma</title>
            <link>http://www.medworm.com/index.php?rid=3866022&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk4xw18g56923u674%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Describe a case of apoplexy of an ACTH-producing pituitary adenoma which resulted not only in an empty sella with concurrent
 hypothyroidism, hypoprolactinemia, and hypogonadism but persistent hypercortisolemia from two distinct extrasellar remnants
 of the original adenoma. Review the literature to identify other similar cases. The patient’s medical history, physical exam,
 lab data, imaging exams and histopathological results were analyzed and compiled into a case report, and an extensive review
 of the literature was performed. Endocrinological data revealed hypercortisolism and an elevated ACTH with an otherwise suppressed
 pituitary axis. A pituitary MRI showed a macroadenoma in the left cavernous sinus in addition to an empty sella. An octreotide
 scan revealed ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3866022</comments>
            <pubDate>Wed, 11 Aug 2010 18:54:27 +0100</pubDate>
            <guid isPermaLink="false">3866022</guid>        </item>
        <item>
            <title>Quantification of day-to-day variability in growth hormone levels in acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=3866023&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx4u2k2466145225k%2F</link>
            <description>This study quantified the magnitude of day-to-day GH variability
 in patients with acromegaly by performing an analysis of previously obtained plasma GH profiles. The analysis was performed
 at the Michigan Clinical Research Unit at the University of Michigan. A total of nine 48&amp;nbsp;h Q10&amp;nbsp;min GH profiles obtained in
 nine patients with active acromegaly were examined. The study was planned after data collection and analysis was conducted
 using Altman–Bland methods. Day 1 vs. Day 2 values were examined. 95% confidence intervals of the D2 vs. D1 ratios were calculated
 on all individual subject data as well as on a single 0800&amp;nbsp;h GH sample and composite mean data for 2-, 5-, 9-, and 24-h sampling
 protocols. Confidence interval range was 0.66–1.50 for the 0800&amp;nbsp;h sample an...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3866023</comments>
            <pubDate>Mon, 09 Aug 2010 19:39:16 +0100</pubDate>
            <guid isPermaLink="false">3866023</guid>        </item>
        <item>
            <title>Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides</title>
            <link>http://www.medworm.com/index.php?rid=3866024&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn131282464622804%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Long-term treatment of acromegaly prevents aggravation and reverses associated heart disease. A previous study has shown a
 temporary increase in serum levels of the N-terminal fraction of pro B-type natriuretic peptide (NT-proBNP) suggesting an
 initial decline in cardiac function when treatment of acromegaly is initiated. This was a three months prospective study investigating
 short-term cardiac effects of treatment in acromegalic patients. Cardiac function was evaluated by the gold standard method
 cardiac magnetic resonance imaging (CMRI) and circulating levels of B-type natriuretic peptides (BNP and NT-proBNP). CMRI
 was performed at baseline and after 3&amp;nbsp;months of treatment. Levels of IGF-I, BNP and NT-proBNP were measured after 0, 1, 2
 and 3&amp;nbsp;months. Ei...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3866024</comments>
            <pubDate>Mon, 09 Aug 2010 19:39:15 +0100</pubDate>
            <guid isPermaLink="false">3866024</guid>        </item>
        <item>
            <title>Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing’s disease</title>
            <link>http://www.medworm.com/index.php?rid=3832519&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj40781n802787017%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Paediatric Cushing’s disease (CD) is usually associated with growth retardation, but there are only few published data on
 skeletal maturation at diagnosis. We analysed factors contributing to skeletal maturation and final height in Asian Indian
 patients with paediatric CD. We conducted retrospective analysis of 48 patients (29 males; 19 females) with mean age: 14.84&amp;nbsp;years
 at diagnosis (range 9–19&amp;nbsp;years). A single observer using the Greulich Pyle method determined the bone age (BA) of each child.
 BA delay, i.e. the difference between chronological age (CA) and BA, was compared with clinical and biochemical variables.
 BA delay was present in 35/48 (73%) patients (mean delay 1.6&amp;nbsp;years, range 0.5–5&amp;nbsp;years) and correlated negatively with height
...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3832519</comments>
            <pubDate>Fri, 06 Aug 2010 07:12:56 +0100</pubDate>
            <guid isPermaLink="false">3832519</guid>        </item>
        <item>
            <title>Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=3810122&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F08w026232g065851%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the study is to assess the rate of any potential adverse effects on women who became pregnant under cabergoline
 (CAB) treatment and to evaluate any effects on the embryo-fetal development and on children who were born from mothers exposed
 to CAB in early weeks of gestation. Observational, retrospective and multicenter study on 103 pregnancies in 90 women with
 hyperprolactinemia. All patients were under CAB at conception. Serum prolactin at baseline was between 30 and 1921&amp;nbsp;ng/ml.
 Duration of therapy before pregnancy ranged from 1 to 120&amp;nbsp;months and doses ranged from 0.125 to 5&amp;nbsp;mg/week. Fetal exposure
 ranged from 3 to 25&amp;nbsp;weeks, 96.9% of patients received CAB during the first trimester of pregnancy and the rest until the second
 one. No s...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3810122</comments>
            <pubDate>Fri, 30 Jul 2010 17:05:52 +0100</pubDate>
            <guid isPermaLink="false">3810122</guid>        </item>
        <item>
            <title>Lymphocytic hypophysitis in a patient presenting with sequential episodes of optic neuritis</title>
            <link>http://www.medworm.com/index.php?rid=3810123&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy02l50k2n54777u2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 41-year-old man presented with left optic neuritis (ON) without evidence of other autoimmune disease or hormonal imbalance.
 MRI showed enlargement of the left optic nerve but no sellar lesion. The patient recovered after steroid therapy but later
 developed right ON and required treatment again. Follow-up MRI revealed an ill-defined, enlarging sellar lesion with enhancement
 extending into the right cavernous sinus, and the patient developed symptoms of fatigue and loss of libido. Hormonal studies
 revealed hypogonadism and hypocortisolism. All laboratory investigation for autoimmune and infectious diseases remained negative.
 A transsphenoidal biopsy of the lesion revealed lymphocytic hypophysitis. The concomitant development of lymphocytic hypophysitis
 and optic n...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3810123</comments>
            <pubDate>Fri, 30 Jul 2010 17:05:51 +0100</pubDate>
            <guid isPermaLink="false">3810123</guid>        </item>
        <item>
            <title>Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma</title>
            <link>http://www.medworm.com/index.php?rid=3785303&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm8x41513h387848t%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11102-010-0237-4Authors
		M. Alberiche Ruano, Hospital Universitario Insular de Gran Canaria Endocrinology Deparment Las Palmas de Gran Canaria 35016 Canary Island SpainM. Boronat Cortés, Hospital Universitario Insular de Gran Canaria Endocrinology Deparment Las Palmas de Gran Canaria 35016 Canary Island SpainA. Ojeda Pino, Hospital Universitario Insular de Gran Canaria Endocrinology Deparment Las Palmas de Gran Canaria 35016 Canary Island SpainC. Rodriguez Perez, Hospital Universitario Insular de Gran Canaria Endocrinology Deparment Las Palmas de Gran Canaria 35016 Canary Island SpainM. Gracía Nuñez, Hospital Universitario Insular de Gran Canaria Endocrinology Deparment Las Palmas de Gran Canaria 35016 Canary Island SpainD. Marrero Arencibia, ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3785303</comments>
            <pubDate>Fri, 23 Jul 2010 11:17:40 +0100</pubDate>
            <guid isPermaLink="false">3785303</guid>        </item>
        <item>
            <title>The clinical significance of MIB-1 labeling index in pituitary adenomas</title>
            <link>http://www.medworm.com/index.php?rid=3773928&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp64415w842512873%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pituitary adenomas are unique in several ways—they are rarely malignant and yet can be invasive of several compartments. Recurrences
 in tumors with bland histological features that have been radically excised are a reason for frustration faced by endocrinologists
 and neurosurgeons in treatment of pituitary adenomas. Several attempts have therefore been made to determine the growth potential
 of pituitary adenomas. The aim of the present study was to define the biological significance of the MIB-1 labelling index
 (MIB-1 LI) in pituitary adenomas. The study included 159 cases of surgically treated pituitary adenoma seen in a single institution.
 MIB-1 LI was not found to be related to age or gender. The mean MIB-1 LI for clinically functional adenomas was marginally
...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3773928</comments>
            <pubDate>Fri, 16 Jul 2010 19:46:55 +0100</pubDate>
            <guid isPermaLink="false">3773928</guid>        </item>
        <item>
            <title>Cost of evaluation of patients with pituitary incidentaloma</title>
            <link>http://www.medworm.com/index.php?rid=3773929&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F30n4573584256545%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11102-010-0241-8Authors
		Benjamin R. Randall, University of Utah Department of Neurosurgery Salt Lake City UT USAKristin L. Kraus, University of Utah Department of Neurosurgery Salt Lake City UT USAMarie F. Simard, University of Utah Department of Pediatrics, Division of Endocrinology Salt Lake City UT USAWilliam T. Couldwell, University of Utah Department of Neurosurgery Salt Lake City UT USA
	

	
		Journal PituitaryOnline ISSN 1573-7403Print ISSN 1386-341X (Source: Pituitary)</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3773929</comments>
            <pubDate>Wed, 14 Jul 2010 23:26:47 +0100</pubDate>
            <guid isPermaLink="false">3773929</guid>        </item>
        <item>
            <title>The autopsy was conducted “Under most inauspicious circumstances:” John Turner, Harvey Cushing’s case XXXII, and his unwitting contributions to the early understanding of acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=3734989&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F37u5026420k61414%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Harvey Cushing’s monograph The Pituitary Body and Its Disorders describes Case XXXII, a 36-year-old man who presented with gigantism in 1910. The detailed post-mortem exam findings are
 prefaced with a cryptic statement, describing “inauspicious circumstances” surrounding the autopsy. Although contemporary
 biographies of Cushing have offered insight into these circumstances, the original surgical file for Case XXXII has not been
 previously reviewed. The original Johns Hopkins Hospital surgical records were reviewed, and the case of John Turner, who
 Cushing identified by name in his monograph The Pituitary Body and Its Disorders, was selected for further review. A review of the original surgical file revealed a typewritten note by Dr. Crowe, one of
 the surgeons...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3734989</comments>
            <pubDate>Wed, 07 Jul 2010 06:00:07 +0100</pubDate>
            <guid isPermaLink="false">3734989</guid>        </item>
        <item>
            <title>Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment</title>
            <link>http://www.medworm.com/index.php?rid=3727841&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc7431453824w2003%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In thyrotoxicosis GH responses to stimuli are diminished and the hypothalamic–pituitary–adrenal axis is hyperactive. There
 are no data on ghrelin or GHRP-6-induced GH, ACTH and cortisol release in treated hyperthyroidism. We, therefore, evaluated
 these responses in 10 thyrotoxic patients before treatment and in 7 of them after treatment. GHRH-induced GH release was also
 studied. Peak GH (μg/L; mean&amp;nbsp;±&amp;nbsp;SE) values after ghrelin (22.6&amp;nbsp;±&amp;nbsp;3.9), GHRP-6 (13.8&amp;nbsp;±&amp;nbsp;2.3) and GHRH (4.9&amp;nbsp;±&amp;nbsp;0.9) were lower
 in hyperthyroidism before treatment compared to controls (ghrelin: 67.6&amp;nbsp;±&amp;nbsp;19.3; GHRP-6: 25.4&amp;nbsp;±&amp;nbsp;2.7; GHRH: 12.2&amp;nbsp;±&amp;nbsp;2.8) and
 did not change after 6&amp;nbsp;months of euthyroidism (ghrelin: 32.7&amp;nbsp;±&amp;nb...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3727841</comments>
            <pubDate>Sun, 04 Jul 2010 22:49:48 +0100</pubDate>
            <guid isPermaLink="false">3727841</guid>        </item>
        <item>
            <title>Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults</title>
            <link>http://www.medworm.com/index.php?rid=3677858&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx547707874w83832%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Langerhans cell histiocytosis (LCH) is a rare granulomatous disease of unknown etiology. We retrospectively reviewed data
 from four patients (3 males and 1 female), mean age 33.5&amp;nbsp;years old (range: 21–40), with histopathological diagnosis of LCH.
 All of them presented with symptoms suggestive of endocrine involvement. The main complaint was goiter in two patients and
 polyuria and polydipsia in three. Before the LCH diagnosis, two patients had unevaluated symptoms of diabetes insipidus (DI)
 and hypogonadism. The mean time from symptoms onset to diagnosis was 6.25&amp;nbsp;years (range: 2–13). Histopathological diagnosis
 was established by total thyroidectomy (TT) biopsy in two patients, skin lesion biopsy in one, and pituitary stalk biopsy
 in the other. In the ...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3677858</comments>
            <pubDate>Fri, 18 Jun 2010 10:40:54 +0100</pubDate>
            <guid isPermaLink="false">3677858</guid>        </item>
        <item>
            <title>Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly?</title>
            <link>http://www.medworm.com/index.php?rid=3653958&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4026u6957l1xv78%2F</link>
            <description>In conclusion, oral estrogen treatment appears to normalize
 serum IGF-1 concentrations in over 70% of women with acromegaly uncured by surgery irrespective of their sensitivity to octreotide
 LAR. We suggest that estrogens may be a temporary cost-effective and safe treatment for women with postoperative persistent
 acromegaly.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0236-5Authors
		Sophie Vallette, Université de Montréal Department of Endocrinology, Centre Hospitalier de l’Université de Montréal, Notre-Dame Hospital 1560 Sherbrooke East Montreal QC CanadaOmar Serri, Université de Montréal Department of Endocrinology, Centre Hospitalier de l’Université de Montréal, Notre-Dame Hospital 1560 Sherbrooke East Montreal QC Canada
	

	
		Journal PituitaryOnline ISSN 15...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3653958</comments>
            <pubDate>Wed, 09 Jun 2010 20:12:52 +0100</pubDate>
            <guid isPermaLink="false">3653958</guid>        </item>
        <item>
            <title>Hypopituitarism following brain injury: when does it occur and how best to test?</title>
            <link>http://www.medworm.com/index.php?rid=3642392&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F92527qj4420463l7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Aim of this review is to highlight how and when Traumatic Brain Injury (TBI) as well as Subarachnoid Haemorrhage (SAH) and
 primary Brain Tumours (pBT) of the Central Nervous System (CNS) can induce hypopituitarism, an under-diagnosed clinical problem.
 Moreover, this review aims to clarify, on the basis of the recent evidences, how these patients have to be tested for pituitary-function.
 Both retrospective and prospective studies recommended that patients with more severe form of Brain Injuries (BI) and in particular,
 those with fractures of the base of the skull or early diabetes insipidus, have to be closely monitored for signs and symptoms
 of endocrine dysfunction. Further studies will be crucial to raise awareness and remind physicians on the prevalence of hypop...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3642392</comments>
            <pubDate>Fri, 04 Jun 2010 16:54:00 +0100</pubDate>
            <guid isPermaLink="false">3642392</guid>        </item>
        <item>
            <title>Hypothalamic pituitary abnormalities in tubercular meningitis at the time of diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=3601081&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw7708257558156u2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tubercular meningitis (TBM) is the most dreaded form of extra pulmonary tuberculosis associated with high morbidity and mortality.
 Various hypothalamic pituitary hormonal abnormalities have been reported to occur years after recovery from disease but there
 are no systematic studies in the literature to evaluate the pituitary hypothalamic dysfunction in patients with TBM at the
 time of presentation. Therefore, the present study was designed to evaluate hypothalamic pituitary abnormalities in newly
 diagnosed patients with TBM. Patient case series. This prospective study included 75 untreated adult patients with TBM diagnosed
 as “definite”, “highly probable” and “probable” TBM by Ahuja’s criteria and in clinical stage 1, 2 or 3 at the time of presentatio...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3601081</comments>
            <pubDate>Fri, 21 May 2010 21:15:47 +0100</pubDate>
            <guid isPermaLink="false">3601081</guid>        </item>
        <item>
            <title>Selective pituitary tumor apoplexy apparently reversed acromegaly in Governor Pio Pico between 1858 and 1873</title>
            <link>http://www.medworm.com/index.php?rid=3544098&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5133k6g2v0263wg2%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s11102-010-0225-8Authors
		Ivan S. Login, University of Virginia Health System Department of Neurology Box 800394 Charlottesville VA 22908 USAJessica Login, Washington Elementary School 825 Taylor Avenue Alameda CA 95401 USAJason C. Bennett, University of Virginia Health Sciences Library Digital Media Consultant Box 800722 Charlottesville VA 22908 USA
	

	
		Journal PituitaryOnline ISSN 1573-7403Print ISSN 1386-341X (Source: Pituitary)</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3544098</comments>
            <pubDate>Thu, 06 May 2010 08:02:29 +0100</pubDate>
            <guid isPermaLink="false">3544098</guid>        </item>
        <item>
            <title>Radiotherapy in paediatric Cushing’s disease: efficacy and long term follow up of pituitary function</title>
            <link>http://www.medworm.com/index.php?rid=3502207&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1v70l415prt332h8%2F</link>
            <description>This study also emphasizes the need of growth hormone statues assessment and timely intervention.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0231-xAuthors
		Shrikrishna V. Acharya, Seth G S Medical College and KEM Hospital Department of Endocrinology Mumbai 12 Maharashtra IndiaRaju A. Gopal, Seth G S Medical College and KEM Hospital Department of Endocrinology Mumbai 12 Maharashtra IndiaJoe Goerge, Seth G S Medical College and KEM Hospital Department of Endocrinology Mumbai 12 Maharashtra IndiaPadma S. Menon, Seth G S Medical College and KEM Hospital Department of Endocrinology Mumbai 12 Maharashtra IndiaTushar R. Bandgar, Seth G S Medical College and KEM Hospital Department of Endocrinology Mumbai 12 Maharashtra IndiaNalini S. Shah, Seth G S Medical College and KEM Hospital D...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3502207</comments>
            <pubDate>Thu, 22 Apr 2010 09:15:30 +0100</pubDate>
            <guid isPermaLink="false">3502207</guid>        </item>
        <item>
            <title>Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=3495603&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07364qt217810626%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been suggested that treatment with adequate dose titration of pegvisomant, a GH antagonist, up to a maximum of 40&amp;nbsp;mg
 daily, can achieve IGF-1 normalisation in virtually all patients with acromegaly. On the other hand, temozolomide (TMZ), an
 alkylating cytostatic agent, has been reported to reduce pituitary tumour size and hormone hypersecretion in a small number
 of aggressive pituitary macroadenomas. In this paper we report the case of a patient resistant to very high doses of pegvisomant
 used in combination with somatostatin analogs (SSA) and to TMZ therapy. The patient, initially a 22&amp;nbsp;year-old man with an invasive
 GH-secreting pituitary macroadenoma (IGF-1, 371% upper limit of normal), had active acromegaly despite a repeat transsphenoidal
 surge...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3495603</comments>
            <pubDate>Wed, 21 Apr 2010 09:22:29 +0100</pubDate>
            <guid isPermaLink="false">3495603</guid>        </item>
        <item>
            <title>Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=3491989&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F26g2r23g21l171xm%2F</link>
            <description>We present a case report of a patient recently treated at our institution for an isolated non-small cell lung cancer metastatic
 lesion to the sella, report the lack of involvement of the pituitary gland in a large single-institution series of treated
 intracranial parenchymal metastases, and review the pertinent literature. We reviewed cranial imaging studies (CT and MRI)
 for 935 metastases in 155 patients treated at our institution over the previous 3&amp;nbsp;years for intracranial metastatic disease.
 Special attention was paid to the skull base to document the presence of any metastatic disease involving the pituitary gland,
 infundibular stalk, sella turcica (including anterior and posterior clinoids), or diaphragm sellae. We found no other involvement
 of the pituitary gland or other s...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3491989</comments>
            <pubDate>Tue, 20 Apr 2010 11:18:10 +0100</pubDate>
            <guid isPermaLink="false">3491989</guid>        </item>
        <item>
            <title>Rosai-Dorfman disease involving the neurohypophysis</title>
            <link>http://www.medworm.com/index.php?rid=3491990&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fax2u733471234375%2F</link>
            <description>We report the case of a 63&amp;nbsp;year-old woman with disseminated Rosai-Dorfman
 disease involving the neurohypophysis and associated with adenohypophysial PRL cell hyperplasia.
 
 
	Content Type Journal ArticleDOI 10.1007/s11102-010-0228-5Authors
		Fabio Rotondo, St. Michael’s Hospital, University of Toronto Department of Laboratory Medicine, Division of Pathology 30 Bond Street Toronto ON M5B 1W8 CanadaDavid G. Munoz, St. Michael’s Hospital, University of Toronto Department of Laboratory Medicine, Division of Pathology 30 Bond Street Toronto ON M5B 1W8 CanadaRichard G. Hegele, St. Michael’s Hospital, University of Toronto Department of Laboratory Medicine, Division of Pathology 30 Bond Street Toronto ON M5B 1W8 CanadaBruce Gray, St. Michael’s Hospital, University of Toronto Depart...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3491990</comments>
            <pubDate>Tue, 20 Apr 2010 11:18:09 +0100</pubDate>
            <guid isPermaLink="false">3491990</guid>        </item>
        <item>
            <title>Polyuria and polydipsia in a young child: diagnostic considerations and identification of novel mutation causing familial neurohypophyseal diabetes insipidus</title>
            <link>http://www.medworm.com/index.php?rid=3484291&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnv84428121qw3241%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 3-year 5-month-old boy was seen for second opinion regarding polydipsia and polyuria. Previously, a diagnosis of primary
 polydipsia was made after normal urine concentration after overnight water deprivation testing. The boy’s father, paternal
 grandfather, and paternal aunt had diabetes insipidus treated with desmopressin acetate. Based on this young boy’s symptoms,
 ability to concentrate urine after informal overnight water deprivation, and family history of diabetes insipidus, we performed
 AVP gene mutation testing. Analysis of the AVP gene revealed a novel mutation G54E that changes a normal glycine to glutamic acid, caused by a guanine to adenine change
 at nucleotide g.1537 (exon 2) of the AVP gene. Commonly, patients with familial neurohypophyseal diabet...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3484291</comments>
            <pubDate>Sat, 17 Apr 2010 16:50:39 +0100</pubDate>
            <guid isPermaLink="false">3484291</guid>        </item>
        <item>
            <title>Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy</title>
            <link>http://www.medworm.com/index.php?rid=3469378&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3krv8445n637m851%2F</link>
            <description>We present a case of acromegaly
 secondary to proven GHRH-secretion by a bronchial carcinoid tumor in a type 1 diabetic subject and document the clinical course
 pre- and post-resection of the tumor and of subsequent octreotide therapy. A 54-year-old Caucasian man was referred for evaluation
 of acromegalic symptoms and significantly increased insulin requirements. He had a history of left lung surgery 20&amp;nbsp;years prior
 for hemoptysis. Initial laboratory results indicated acromegaly. Fasting serum growth hormone (GH): 26.1&amp;nbsp;ng/mL (0–5&amp;nbsp;ng/mL),
 insulin-like growth factor 1 (IGF-1): 635&amp;nbsp;ng/mL (87–283&amp;nbsp;ng/mL), GH at 60&amp;nbsp;min post-ingestion of 75 grams of oral glucose during
 a glucose tolerance test: 8.3&amp;nbsp;ng/mL (normal &amp;lt;1&amp;nbsp;ng/mL). Pituitary magnetic reso...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3469378</comments>
            <pubDate>Thu, 08 Apr 2010 18:02:46 +0100</pubDate>
            <guid isPermaLink="false">3469378</guid>        </item>
        <item>
            <title>Immediate postoperative cortisol levels accurately predict postoperative hypothalamic–pituitary–adrenal axis function after transsphenoidal surgery for pituitary tumors</title>
            <link>http://www.medworm.com/index.php?rid=3409534&amp;cid=s_33309_15_f&amp;fid=33309&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe087143g1w261617%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Accurate assessment of the hypothalamic–pituitary–adrenal (HPA) axis is critical for the appropriate management of patients
 with pituitary adenoma after transsphenoidal surgery. We examine the role of immediate postoperative cortisol levels to assess
 hypothalamic–pituitary–adrenal axis (HPA) axis function post-operatively. We performed preoperative cortrosyn stimulation
 test (CST) and measured immediate postoperative serum cortisol levels in 100 patients undergoing 104 transsphenoidal surgeries.
 These results were compared to those of the CST at 4–6&amp;nbsp;weeks postoperatively, which served as a measure of HPA axis function.
 The ability of immediate postoperative, day of surgery (DOS) cortisol levels to predict normal HPA axis function was determined
 usin...</description>
            <author>Pituitary</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3409534</comments>
            <pubDate>Thu, 25 Mar 2010 19:07:49 +0100</pubDate>
            <guid isPermaLink="false">3409534</guid>        </item>
    </channel>
</rss>

